-
1
-
-
1342280974
-
Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines
-
Massi, P.; Vaccani, A.; Ceruti, S.; Colombo, A.; Abbracchio, M.P.; Parolaro, D. Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines. J. Pharmacol. Exp. Ther., 2004, 308(3), 838-845
-
(2004)
J. Pharmacol. Exp. Ther
, vol.308
, Issue.3
, pp. 838-845
-
-
Massi, P.1
Vaccani, A.2
Ceruti, S.3
Colombo, A.4
Abbracchio, M.P.5
Parolaro, D.6
-
2
-
-
84944327357
-
In vitro anticancer activity of plant-derived cannabidiol on prostate cancer cell lines
-
Epub ahead of print]
-
Sharma, M.; Hudson, J.B.; Adomat, H.; Guns, E.; Cox, M.E. In vitro anticancer activity of plant-derived cannabidiol on prostate cancer cell lines. Pharm. Pharmacol., 2014, Epub ahead of print].
-
(2014)
Pharm. Pharmacol
-
-
Sharma, M.1
Hudson, J.B.2
Adomat, H.3
Guns, E.4
Cox, M.E.5
-
3
-
-
0036278032
-
Targeting the endocannabinoid system in cancer therapy: A call for further research
-
Di Marzo, V. Targeting the endocannabinoid system in cancer therapy: a call for further research. Nat. Med., 2002, 8(6), 547.
-
(2002)
Nat. Med
, vol.8
, Issue.6
, pp. 547
-
-
Di Marzo, V.1
-
4
-
-
0036669523
-
Cannabinoids and cell fate
-
Guzmán, M.; Sánchez, C.; Galve-Roperh, I. Cannabinoids and cell fate. Pharmacol. Ther., 2002, 95(2), 175-184.
-
(2002)
Pharmacol. Ther
, vol.95
, Issue.2
, pp. 175-184
-
-
Guzmán, M.1
Sánchez, C.2
Galve-Roperh, I.3
-
5
-
-
33747624175
-
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
-
Ligresti, A.; Moriello, A.S.; Starowicz, K.; Matias, I.; Pisanti, S.; De Petrocellis, L.; Laezza, C.; Portella, G.; Bifulco, M.; Di Marzo, V. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J. Pharmacol. Exp. Ther., 2006, 318(3), 1375-1387.
-
(2006)
J. Pharmacol. Exp. Ther
, vol.318
, Issue.3
, pp. 1375-1387
-
-
Ligresti, A.1
Moriello, A.S.2
Starowicz, K.3
Matias, I.4
Pisanti, S.5
De Petrocellis, L.6
Laezza, C.7
Portella, G.8
Bifulco, M.9
Di Marzo, V.10
-
6
-
-
83055161839
-
Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent
-
Sreevalsan, S.; Joseph, S.; Jutooru, I.; Chadalapaka, G.; Safe, S.H. Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent. Anticancer Res., 2011, 31(11), 3799-3807.
-
(2011)
Anticancer Res
, vol.31
, Issue.11
, pp. 3799-3807
-
-
Sreevalsan, S.1
Joseph, S.2
Jutooru, I.3
Chadalapaka, G.4
Safe, S.H.5
-
7
-
-
70349189518
-
Non-psychotropic plant cannabinoids: New therapeutic opportunities from an ancient herb
-
Izzo, A.A.; Borrelli, F.; Capasso, R.; Di Marzo, V.; Mechoulam, R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol. Sci., 2009, 30(10), 515-527.
-
(2009)
Trends Pharmacol. Sci
, vol.30
, Issue.10
, pp. 515-527
-
-
Izzo, A.A.1
Borrelli, F.2
Capasso, R.3
Di Marzo, V.4
Mechoulam, R.5
-
8
-
-
33747348065
-
-
Springer: USA
-
Mackie, K. In Cannabinoids; Springer: USA 2005, pp. 299-325.
-
(2005)
Cannabinoids
, pp. 299-325
-
-
Mackie, K.1
-
9
-
-
0031749186
-
Cannabinoid receptors and their endogenous agonists
-
Felder, C.C.; Glass, M. Cannabinoid receptors and their endogenous agonists. Annu. Rev. Pharmacol. Toxicol., 1998, 38(1), 179-200.
-
(1998)
Annu. Rev. Pharmacol. Toxicol
, vol.38
, Issue.1
, pp. 179-200
-
-
Felder, C.C.1
Glass, M.2
-
10
-
-
84906238485
-
Cannabinoids as therapeutic agents in cancer: Current status and future implications
-
Chakravarti, B.; Ravi, J.; Ganju, R.K. Cannabinoids as therapeutic agents in cancer: current status and future implications. Oncotarget, 2014, 5(15), 5852.
-
(2014)
Oncotarget
, vol.5
, Issue.15
, pp. 5852
-
-
Chakravarti, B.1
Ravi, J.2
Ganju, R.K.3
-
11
-
-
70349289122
-
Cannabinoids in the treatment of cancer
-
Alexander, A.; Smith, P.F.; Rosengren, R.J. Cannabinoids in the treatment of cancer. Cancer Lett., 2009, 285(1), 6-12.
-
(2009)
Cancer Lett
, vol.285
, Issue.1
, pp. 6-12
-
-
Alexander, A.1
Smith, P.F.2
Rosengren, R.J.3
-
12
-
-
0142166330
-
Cannabinoids potential anticancer agents
-
Guzman, M. Cannabinoids: potential anticancer agents. Nat. Rev. Cancer, 2003, 3(10), 745-755.
-
(2003)
Nat. Rev. Cancer
, vol.3
, Issue.10
, pp. 745-755
-
-
Guzman, M.1
-
13
-
-
83555174546
-
Phytocannabinoids as novel therapeutic agents in cns disorders
-
Hill, A.J.; Williams, C.M.; Whalley, B.J.; Stephens, G.J. Phytocannabinoids as novel therapeutic agents in CNS disorders. Pharmacol. Ther., 2012, 133(1), 79-97.
-
(2012)
Pharmacol. Ther
, vol.133
, Issue.1
, pp. 79-97
-
-
Hill, A.J.1
Williams, C.M.2
Whalley, B.J.3
Stephens, G.J.4
-
14
-
-
77449127143
-
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1
-
Ramer, R.; Merkord, J.; Rohde, H.; Hinz, B. Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1. Biochem. Pharmacol., 2010, 79(7), 955-966.
-
(2010)
Biochem. Pharmacol
, vol.79
, Issue.7
, pp. 955-966
-
-
Ramer, R.1
Merkord, J.2
Rohde, H.3
Hinz, B.4
-
15
-
-
11944262124
-
Cannabinoids and cancer: Causation, remediation, and palliation
-
Hall, W.; Christie, M.; Currow, D. Cannabinoids and cancer: causation, remediation, and palliation. Lancet Oncol., 2005, 6(1), 35-42.
-
(2005)
Lancet Oncol
, vol.6
, Issue.1
, pp. 35-42
-
-
Hall, W.1
Christie, M.2
Currow, D.3
-
16
-
-
84857041624
-
Cannabidiol a non-psychotropic plant-derived cannabinoid decreases inflammation in a murine model of acute lung injury: Role for the adenosine a 2a receptor
-
Ribeiro, A.; Ferraz-de-Paula, V.; Pinheiro, M.L.; Vitoretti, L.B.; Mariano-Souza, D.P.; Quinteiro-Filho, W.M.; Akamine, A.T.; Almeida, V.I.; Quevedo, J.; Dal-Pizzol, F. Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A 2A receptor. Eur. J. Pharmacol., 2012, 678(1), 78-85.
-
(2012)
Eur. J. Pharmacol
, vol.678
, Issue.1
, pp. 78-85
-
-
Ribeiro, A.1
Ferraz-De-Paula, V.2
Pinheiro, M.L.3
Vitoretti, L.B.4
Mariano-Souza, D.P.5
Quinteiro-Filho, W.M.6
Akamine, A.T.7
Almeida, V.I.8
Quevedo, J.9
Dal-Pizzol, F.10
-
17
-
-
84933058636
-
Evaluation of phytocannabinoids from high-potency cannabis sativa using in vitro bioassays to determine structure-Activity relationships for cannabinoid receptor 1 and cannabinoid receptor 2
-
Husni, A.S.; McCurdy, C.R.; Radwan, M.M.; Ahmed, S.A.; Slade, D.; Ross, S.A.; ElSohly, M.A.; Cutler, S.J. Evaluation of phytocannabinoids from high-potency Cannabis sativa using in vitro bioassays to determine structure-Activity relationships for cannabinoid receptor 1 and cannabinoid receptor 2. Med. Chem. Res., 2014, 23 (9), 4295-4300.
-
(2014)
Med. Chem. Res
, vol.23
, Issue.9
, pp. 4295-4300
-
-
Husni, A.S.1
McCurdy, C.R.2
Radwan, M.M.3
Ahmed, S.A.4
Slade, D.5
Ross, S.A.6
ElSohly, M.A.7
Cutler, S.J.8
-
19
-
-
77952635291
-
Phytocannabinoids beyond the cannabis plant-do they exist?
-
Gertsch, J.; Pertwee, R.G.; Di Marzo, V. Phytocannabinoids beyond the Cannabis plant-do they exist? Br. J. Pharmacol., 2010, 160(3), 523-529.
-
(2010)
Br J. Pharmacol
, vol.160
, Issue.3
, pp. 523-529
-
-
Gertsch, J.1
Pertwee, R.G.2
Di Marzo, V.3
-
20
-
-
34548481515
-
Phytocannabinoids in cannabis sativa: Recent studies on biosynthetic enzymes
-
Taura, F.; Sirikantaramas, S.; Shoyama, Y.; Shoyama, Y.; Morimoto, S. Phytocannabinoids in Cannabis sativa: recent studies on biosynthetic enzymes. Chem. Biodivers., 2007, 4(8), 1649-1663.
-
(2007)
Chem. Biodivers
, vol.4
, Issue.8
, pp. 1649-1663
-
-
Taura, F.1
Sirikantaramas, S.2
Shoyama, Y.3
Shoyama, Y.4
Morimoto, S.5
-
21
-
-
57449118210
-
Phytocannabinoids and endocannabinoids
-
Fisar, Z. Phytocannabinoids and endocannabinoids. Curr. Drug Abuse Rev., 2009, 2(1), 51-75.
-
(2009)
Curr. Drug Abuse Rev
, vol.2
, Issue.1
, pp. 51-75
-
-
Fisar, Z.1
-
23
-
-
0037173524
-
In vitro experiment optimization for measuring tetrahydrocannabinol skin permeation
-
Challapalli, P.V.; Stinchcomb, A.L. In vitro experiment optimization for measuring tetrahydrocannabinol skin permeation. Int. J. Pharm., 2002, 241(2), 329-339.
-
(2002)
Int. J. Pharm
, vol.241
, Issue.2
, pp. 329-339
-
-
Challapalli, P.V.1
Stinchcomb, A.L.2
-
24
-
-
0034685707
-
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid cb 2 receptor
-
Buckley, N.E.; McCoy, K.L.; Mezey, E.; Bonner, T.; Zimmer, A.; Felder, C.C.; Glass, M.; Zimmer, A. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB 2 receptor. Eur. J. Pharmacol., 2000, 396(2), 141-149.
-
(2000)
Eur. J. Pharmacol
, vol.396
, Issue.2
, pp. 141-149
-
-
Buckley, N.E.1
McCoy, K.L.2
Mezey, E.3
Bonner, T.4
Zimmer, A.5
Felder, C.C.6
Glass, M.7
Zimmer, A.8
-
25
-
-
33646062552
-
Cb 2 cannabinoid receptor mediation of antinociception
-
Ibrahim, M.M.; Rude, M.L.; Stagg, N.J.; Mata, H.P.; Lai, J.; Vanderah, T.W.; Porreca, F.; Buckley, N.E.; Makriyannis, A.; Malan, T.P. CB 2 cannabinoid receptor mediation of antinociception. Pain, 2006, 122(1), 36-42.
-
(2006)
Pain
, vol.122
, Issue.1
, pp. 36-42
-
-
Ibrahim, M.M.1
Rude, M.L.2
Stagg, N.J.3
Mata, H.P.4
Lai, J.5
Vanderah, T.W.6
Porreca, F.7
Buckley, N.E.8
Makriyannis, A.9
Malan, T.P.10
-
26
-
-
42349116262
-
Cannabinoid receptors: Where they are and what they do
-
Mackie, K. Cannabinoid receptors: where they are and what they do. J. Neuroendocrinol., 2008, 20(s1), 10-14.
-
(2008)
J. Neuroendocrinol
, vol.20
, Issue.S1
, pp. 10-14
-
-
Mackie, K.1
-
27
-
-
17044366690
-
Cannabinoid therapeutics: High hopes for the future
-
Hensen, B. Cannabinoid therapeutics: high hopes for the future. Drug Discov. Today, 2005, 10(7), 459-462.
-
(2005)
Drug Discov. Today
, vol.10
, Issue.7
, pp. 459-462
-
-
Hensen, B.1
-
28
-
-
84920829439
-
Are cannabidiol and delta-9-?tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
-
McPartland, J.M.; Duncan, M.; Di Marzo, V.; Pertwee, R.G. Are cannabidiol and delta-9-?tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. Br. J. Pharmacol., 2015, 172(3), 737-753.
-
(2015)
Br. J. Pharmacol
, vol.172
, Issue.3
, pp. 737-753
-
-
McPartland, J.M.1
Duncan, M.2
Di Marzo, V.3
Pertwee, R.G.4
-
29
-
-
33645502759
-
The pharmacology of cannabinoid receptors and their ligands: An overview
-
Pertwee, R. The pharmacology of cannabinoid receptors and their ligands: an overview. Int. J. Obes., 2006, 30, S13-S18.
-
(2006)
Int. J. Obes
, vol.30
, pp. S13-S18
-
-
Pertwee, R.1
-
30
-
-
84908134717
-
Differences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures
-
Rosenthaler, S.; Pöhn, B.; Kolmanz, C.; Huu, C.N.; Krewenka, C.; Huber, A.; Kranner, B.; Rausch, W.-D.; Moldzio, R. Differences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures. Neurotoxicol. Teratol., 2014, 46, 49-56.
-
(2014)
Neurotoxicol. Teratol
, vol.46
, pp. 49-56
-
-
Rosenthaler, S.1
Pöhn, B.2
Kolmanz, C.3
Huu, C.N.4
Krewenka, C.5
Huber, A.6
Kranner, B.7
Rausch, W.-D.8
Moldzio, R.9
-
31
-
-
0025236913
-
Cannabinoid receptor localization in brain
-
Herkenham, M.; Lynn, A.B.; Little, M.D.; Johnson, M.R.; Melvin, L.S.; De Costa, B.R.; Rice, K.C. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. USA, 1990, 87(5), 1932-1936.
-
(1990)
Proc. Natl. Acad. Sci. USA
, vol.87
, Issue.5
, pp. 1932-1936
-
-
Herkenham, M.1
Lynn, A.B.2
Little, M.D.3
Johnson, M.R.4
Melvin, L.S.5
De Costa, B.R.6
Rice, K.C.7
-
32
-
-
0025325535
-
Structure of a cannabinoid receptor and functional expression of the cloned cdna
-
Matsuda, L.A.; Lolait, S.J.; Brownstein, M.J.; Young, A.C.; Bonner, T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 1990, (346), 561-564.
-
(1990)
Nature
, vol.346
, pp. 561-564
-
-
Matsuda, L.A.1
Lolait, S.J.2
Brownstein, M.J.3
Young, A.C.4
Bonner, T.I.5
-
34
-
-
77952283131
-
Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities
-
Bosier, B.; Muccioli, G.G.; Hermans, E.; Lambert, D.M. Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities. Bio. Chem. Pharmacol., 2010, 80(1), 1-12.
-
(2010)
Bio. Chem. Pharmacol
, vol.80
, Issue.1
, pp. 1-12
-
-
Bosier, B.1
Muccioli, G.G.2
Hermans, E.3
Lambert, D.M.4
-
35
-
-
33747348065
-
-
Springer: USA
-
Howlett, A. In Cannabinoids; Springer: USA, 2005, pp. 53-79.
-
(2005)
Cannabinoids
, pp. 53-79
-
-
Howlett, A.1
-
36
-
-
18444376760
-
International union of pharmacology. Xxvii. Classification of cannabinoid receptors
-
Howlett, A.; Barth, F.; Bonner, T.; Cabral, G.; Casellas, P.; Devane, W.; Felder, C.; Herkenham, M.; Mackie, K.; Martin, B. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev., 2002, 54(2), 161-202.
-
(2002)
Pharmacol. Rev
, vol.54
, Issue.2
, pp. 161-202
-
-
Howlett, A.1
Barth, F.2
Bonner, T.3
Cabral, G.4
Casellas, P.5
Devane, W.6
Felder, C.7
Herkenham, M.8
Mackie, K.9
Martin, B.10
-
37
-
-
84883341895
-
Critical appraisal of the potential use of cannabinoid in cancer management
-
Cridge, B.J.; Rosengren, R.J. Critical appraisal of the potential use of cannabinoid in cancer management. Cancer Manag. Res., 2013, 5, 301.
-
(2013)
Cancer Manag. Res
, vol.5
, pp. 301
-
-
Cridge, B.J.1
Rosengren, R.J.2
-
38
-
-
84924138528
-
Phytocannabinoids and epilepsy
-
Santos, R.; Hallak, J.; Leite, J.; Zuardi, A.; Crippa, J. Phytocannabinoids and epilepsy. J. Clin. Pharm. Ther., 2015, 40(2), 135-43.
-
(2015)
J. Clin. Pharm. Ther
, vol.40
, Issue.2
, pp. 135-143
-
-
Santos, R.1
Hallak, J.2
Leite, J.3
Zuardi, A.4
Crippa, J.5
-
39
-
-
84892453118
-
Analytical approaches for the determination of phytocannabinoids and endocannabinoids in human matrices
-
Battista, N.; Sergi, M.; Montesano, C.; Napoletano, S.; Compagnone, D.; Maccarrone, M. Analytical approaches for the determination of phytocannabinoids and endocannabinoids in human matrices. Drug Test. Anal., 2014, 6(1-2), 7-16.
-
(2014)
Drug Test. Anal
, vol.6
, Issue.1-2
, pp. 7-16
-
-
Battista, N.1
Sergi, M.2
Montesano, C.3
Napoletano, S.4
Compagnone, D.5
Maccarrone, M.6
-
40
-
-
84924267939
-
Medical marijuana for cancer
-
Kramer, J.L. Medical marijuana for cancer. CA: a cancer CA Cancer J. Clin., 2015, 65(2), 109-22.
-
(2015)
CA: A Cancer CA Cancer J. Clin
, vol.65
, Issue.2
, pp. 109-122
-
-
Kramer, J.L.1
-
41
-
-
84902304606
-
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
-
Devinsky, O.; Cilio, M.R.; Cross, H.; Fernandez-?Ruiz, J.; French, J.; Hill, C.; Katz, R.; Di Marzo, V.; Jutras-?Aswad, D.; Notcutt, W.G. Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia, 2014, 55(6), 791-802.
-
(2014)
Epilepsia
, vol.55
, Issue.6
, pp. 791-802
-
-
Devinsky, O.1
Cilio, M.R.2
Cross, H.3
Fernandez-Ruiz, J.4
French, J.5
Hill, C.6
Katz, R.7
Di Marzo, V.8
Jutras-Aswad, D.9
Notcutt, W.G.10
-
42
-
-
84862127777
-
The intersection between cannabis and cancer in the United States
-
Bowles, D.W.; O'Bryant, C.L.; Camidge, D.R.; Jimeno, A. The intersection between cannabis and cancer in the United States. Crit. Rev. Oncol. Hematol., 2012, 83(1), 1-10.
-
(2012)
Crit. Rev. Oncol. Hematol
, vol.83
, Issue.1
, pp. 1-10
-
-
Bowles, D.W.1
O'Bryant, C.L.2
Camidge, D.R.3
Jimeno, A.4
-
43
-
-
33746125474
-
Delta-9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through cdc2 regulation
-
Caffarel, M.M.; Sarrió, D.; Palacios, J.; Guzmán, M.; Sánchez, C. delta-9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation. Cancer Res., 2006, 66(13), 6615-6621.
-
(2006)
Cancer Res
, vol.66
, Issue.13
, pp. 6615-6621
-
-
Caffarel, M.M.1
Sarrió, D.2
Palacios, J.3
Guzmán, M.4
Sánchez, C.5
-
44
-
-
79960336157
-
The endocannabinoid system and cancer: Therapeutic implication
-
Guindon, J.; Hohmann, A.G. The endocannabinoid system and cancer: therapeutic implication. Br. J. Pharmacol., 2011, 163(7), 1447-1463.
-
(2011)
Br. J. Pharmacol
, vol.163
, Issue.7
, pp. 1447-1463
-
-
Guindon, J.1
Hohmann, A.G.2
-
45
-
-
0032493378
-
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
-
De Petrocellis, L.; Melck, D.; Palmisano, A.; Bisogno, T.; Laezza, C.; Bifulco, M.; Di Marzo, V. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc. Natl. Acad. Sci. USA, 1998, 95(14), 8375-8380.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, Issue.14
, pp. 8375-8380
-
-
De Petrocellis, L.1
Melck, D.2
Palmisano, A.3
Bisogno, T.4
Laezza, C.5
Bifulco, M.6
Di Marzo, V.7
-
46
-
-
50649112355
-
Jund is involved in the antiproliferative effect of delta-9-tetrahydrocannabinol on human breast cancer cells
-
Caffarel, M.; Moreno-Bueno, G.; Cerutti, C.; Palacios, J.; Guzman, M.; Mechta-Grigoriou, F.; Sanchez, C. JunD is involved in the antiproliferative effect of delta-9-tetrahydrocannabinol on human breast cancer cells. Oncogene, 2008, 27(37), 5033-5044.
-
(2008)
Oncogene
, vol.27
, Issue.37
, pp. 5033-5044
-
-
Caffarel, M.1
Moreno-Bueno, G.2
Cerutti, C.3
Palacios, J.4
Guzman, M.5
Mechta-Grigoriou, F.6
Sanchez, C.7
-
47
-
-
14844362003
-
Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response
-
McKallip, R.J.; Nagarkatti, M.; Nagarkatti, P.S. Delta-9-Tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J. Immunol., 2005, 174(6), 3281-3289.
-
(2005)
J. Immunol
, vol.174
, Issue.6
, pp. 3281-3289
-
-
McKallip, R.J.1
Nagarkatti, M.2
Nagarkatti, P.S.3
-
48
-
-
84865417165
-
Cannabinoids a new hope for breast cancer therapy?
-
Caffarel, M.M.; Andradas, C.; Pérez-Gómez, E.; Guzmán, M.; Sánchez, C. Cannabinoids: A new hope for breast cancer therapy? Cancer Treat. Rev., 2012, 38(7), 911-918.
-
(2012)
Cancer Treat Rev
, vol.38
, Issue.7
, pp. 911-918
-
-
Caffarel, M.M.1
Andradas, C.2
Pérez-Gómez, E.3
Guzmán, M.4
Sánchez, C.5
-
49
-
-
38049143945
-
Delta-9-tetrahydrocannabinol inhibits epithelial growth factorinduced lung cancer cell migration in vitro as well as its growth and metastasis in vivo
-
Preet, A.; Ganju, R.; Groopman, J. Delta-9-Tetrahydrocannabinol inhibits epithelial growth factorinduced lung cancer cell migration in vitro as well as its growth and metastasis in vivo. Oncogene, 2008, 27(3), 339-346.
-
(2008)
Oncogene
, vol.27
, Issue.3
, pp. 339-346
-
-
Preet, A.1
Ganju, R.2
Groopman, J.3
-
50
-
-
77954789824
-
Cannabinoids reduce erbb2-driven breast cancer progression through akt inhibition
-
Caffarel, M.M.; Andradas, C.; Mira, E.; Pérez-Gómez, E.; Cerutti, C.; Moreno-Bueno, G.; Flores, J.M.; García-Real, I.; Palacios, J.; Mañes, S. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. Mol. Cancer, 2010, 9(196), 4598-4599.
-
(2010)
Mol. Cancer
, vol.9
, Issue.196
, pp. 4598-4599
-
-
Caffarel, M.M.1
Andradas, C.2
Mira, E.3
Pérez-Gómez, E.4
Cerutti, C.5
Moreno-Bueno, G.6
Flores, J.M.7
García-Real, I.8
Palacios, J.9
Mañes, S.10
-
51
-
-
34247499539
-
Insights from transgenic mouse models of erbb2-induced breast cancer
-
Ursini-Siegel, J.; Schade, B.; Cardiff, R.D.; Muller, W.J. Insights from transgenic mouse models of ERBB2-induced breast cancer. Nat. Rev. Cancer, 2007, 7(5), 389-397.
-
(2007)
Nat. Rev. Cancer
, vol.7
, Issue.5
, pp. 389-397
-
-
Ursini-Siegel, J.1
Schade, B.2
Cardiff, R.D.3
Muller, W.J.4
-
52
-
-
39249083222
-
Delta-9-tetrahydrocannabinol enhances mcf-7 cell proliferation via cannabinoid receptor-independent signaling
-
Takeda, S.; Yamaori, S.; Motoya, E.; Matsunaga, T.; Kimura, T.; Yamamoto, I.; Watanabe, K. Delta-9-Tetrahydrocannabinol enhances MCF-7 cell proliferation via cannabinoid receptor-independent signaling. Toxicology, 2008, 245(1), 141-146.
-
(2008)
Toxicology
, vol.245
, Issue.1
, pp. 141-146
-
-
Takeda, S.1
Yamaori, S.2
Motoya, E.3
Matsunaga, T.4
Kimura, T.5
Yamamoto, I.6
Watanabe, K.7
-
53
-
-
63149189746
-
Modulation of delta-9-tetrahydrocannabinol-induced mcf-7 breast cancer cell growth by cyclooxygenase and aromatase
-
Takeda, S.; Yamamoto, I.; Watanabe, K. Modulation of delta-9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromatase. Toxicology, 2009, 259(1), 25-32.
-
(2009)
Toxicology
, vol.259
, Issue.1
, pp. 25-32
-
-
Takeda, S.1
Yamamoto, I.2
Watanabe, K.3
-
54
-
-
0034235808
-
Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a cb2 receptor-mediated, cytokine-dependent pathway
-
Zhu, L.X.; Sharma, S.; Stolina, M.; Gardner, B.; Roth, M.D.; Tashkin, D.P.; Dubinett, S.M. Delta-9-Tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J. Immunol., 2000, 165(1), 373-380.
-
(2000)
J. Immunol
, vol.165
, Issue.1
, pp. 373-380
-
-
Zhu, L.X.1
Sharma, S.2
Stolina, M.3
Gardner, B.4
Roth, M.D.5
Tashkin, D.P.6
Dubinett, S.M.7
-
55
-
-
33845627660
-
Cannabinoid receptors as novel targets for the treatment of melanoma
-
Blázquez, C.; Carracedo, A.; Barrado, L.; Real, P.J.; Fernández-Luna, J.L.; Velasco, G.; Malumbres, M.; Guzmán, M. Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB J., 2006, 20, (14), 2633-2635.
-
(2006)
FASEB J
, vol.20
, Issue.14
, pp. 2633-2635
-
-
Blázquez, C.1
Carracedo, A.2
Barrado, L.3
Real, P.J.4
Fernández-Luna, J.L.5
Velasco, G.6
Malumbres, M.7
Guzmán, M.8
-
56
-
-
80052532033
-
Crosstalk between chemokine receptor cxcr4 and cannabinoid receptor cb2 in modulating breast cancer growth and invasion
-
Nasser, M.W.; Qamri, Z.; Deol, Y.S.; Smith, D.; Shilo, K.; Zou, X.; Ganju, R.K. Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion. PLoS One, 2011, 6(9), e23901.
-
(2011)
PLoS One
, vol.6
, Issue.9
, pp. e23901
-
-
Nasser, M.W.1
Qamri, Z.2
Deol, Y.S.3
Smith, D.4
Shilo, K.5
Zou, X.6
Ganju, R.K.7
-
57
-
-
26844566936
-
Toxicity and carcinogenicity of delta-9-tetrahydrocannabinol in fischer rats and b6c3f1 mice
-
Chan, P.; Sills, R.; Braun, A.; Haseman, J.; Bucher, J. Toxicity and carcinogenicity of delta-9-tetrahydrocannabinol in Fischer rats and B6C3F1 mice. Toxicol. Sci., 1996, 30(1), 109-117.
-
(1996)
Toxicol. Sci
, vol.30
, Issue.1
, pp. 109-117
-
-
Chan, P.1
Sills, R.2
Braun, A.3
Haseman, J.4
Bucher, J.5
-
58
-
-
0034654660
-
The cb1 cannabinoid receptor is coupled to the activation of protein kinase b/akt
-
Gómez, d.P.T.; Velasco, G.; Guzman, M. The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt. Biochem. J., 2000, 347, 369-373.
-
(2000)
Biochem. J
, Issue.347
, pp. 369-373
-
-
Gómez, D.P.T.1
Velasco, G.2
Guzman, M.3
-
59
-
-
4644226099
-
Cannabinoids down-regulate pi3k/akt and erk signalling pathways and activate proapoptotic function of bad protein
-
Ellert-Miklaszewska, A.; Kaminska, B.; Konarska, L. Cannabinoids down-regulate PI3K/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein. Cell. Signal., 2005, 17(1), 25-37.
-
(2005)
Cell. Signal
, vol.17
, Issue.1
, pp. 25-37
-
-
Ellert-Miklaszewska, A.1
Kaminska, B.2
Konarska, L.3
-
60
-
-
17144470224
-
Activation of phosphoinositide 3-kinase/pkb pathway by cb 1 and cb 2 cannabinoid receptors expressed in prostate pc-3 cells. Involvement in raf-1 stimulation and ngf induction
-
Sánchez, G.; Ruiz-Llorente, L.; Sánchez, A.M. Activation of phosphoinositide 3-kinase/PKB pathway by CB 1 and CB 2 cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction. Cell. Signal., 2003, 15(9), 851-859.
-
(2003)
Cell. Signal
, vol.15
, Issue.9
, pp. 851-859
-
-
Sánchez, G.1
Ruiz-Llorente, L.2
Sánchez, A.M.3
-
61
-
-
0032189381
-
Protein kinase b (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation
-
Coffer, P.; Jin, J.; Woodgett, J. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J., 1998, 335, 1-13.
-
(1998)
Biochem. J
, vol.335
, pp. 1-13
-
-
Coffer, P.1
Jin, J.2
Woodgett, J.3
-
62
-
-
35348910284
-
The cannabinoid delta-9-?tetrahydrocannabinol inhibits ras-?mapk and pi3k-?akt survival signalling and induces bad-?mediated apoptosis in colorectal cancer cells
-
Greenhough, A.; Patsos, H.A.; Williams, A.C.; Paraskeva, C. The cannabinoid delta-9-?tetrahydrocannabinol inhibits RAS-?MAPK and PI3K-?AKT survival signalling and induces BAD-?mediated apoptosis in colorectal cancer cells. Int. J. Cancer, 2007, 121(10), 2172-2180.
-
(2007)
Int. J. Cancer
, vol.121
, Issue.10
, pp. 2172-2180
-
-
Greenhough, A.1
Patsos, H.A.2
Williams, A.C.3
Paraskeva, C.4
-
63
-
-
0024593647
-
Antisense RNA-induced reduction in murine timp levels confers oncogenicity on swiss 3t3 cells
-
Khokha, R.; Waterhouse, P.; Yagel, S.; Lala, P.K.; Overall, C.M.; Norton, G.; Denhardt, D.T. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science, 1989, 243(4893), 947-950.
-
(1989)
Science
, vol.243
, Issue.4893
, pp. 947-950
-
-
Khokha, R.1
Waterhouse, P.2
Yagel, S.3
Lala, P.K.4
Overall, C.M.5
Norton, G.6
Denhardt, D.T.7
-
64
-
-
0347356412
-
Aav-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo
-
Zacchigna, S.; Zentilin, L.; Morini, M.; Dell'Eva, R.; Noonan, D.M.; Albini, A.; Giacca, M. AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo. Cancer Gene Ther., 2004, 11(1), 73-80.
-
(2004)
Cancer Gene Ther
, vol.11
, Issue.1
, pp. 73-80
-
-
Zacchigna, S.1
Zentilin, L.2
Morini, M.3
Dell'Eva, R.4
Noonan, D.M.5
Albini, A.6
Giacca, M.7
-
65
-
-
38049185265
-
Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1
-
Ramer, R.; Hinz, B. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1. J. Natl. Cancer Inst., 2008, 100(1), 59-69.
-
(2008)
J. Natl. Cancer Inst
, vol.100
, Issue.1
, pp. 59-69
-
-
Ramer, R.1
Hinz, B.2
-
66
-
-
84860895849
-
Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1
-
Ramer, R.; Bublitz, K.; Freimuth, N.; Merkord, J.; Rohde, H.; Haustein, M.; Borchert, P.; Schmuhl, E.; Linnebacher, M.; Hinz, B. Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. FASEB J., 2012, 26(4), 1535-1548.
-
(2012)
FASEB J
, vol.26
, Issue.4
, pp. 1535-1548
-
-
Ramer, R.1
Bublitz, K.2
Freimuth, N.3
Merkord, J.4
Rohde, H.5
Haustein, M.6
Borchert, P.7
Schmuhl, E.8
Linnebacher, M.9
Hinz, B.10
-
67
-
-
37349095918
-
Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: A new marker of cannabinoid antitumoral activity?
-
Blázquez, C.; Carracedo, A.; Salazar, M.; Lorente, M.; Egia, A.; González-Feria, L.; Haro, A.; Velasco, G.; Guzmán, M. Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity? Neuropharmacology, 2008, 54(1), 235-243.
-
(2008)
Neuropharmacology
, vol.54
, Issue.1
, pp. 235-243
-
-
Blázquez, C.1
Carracedo, A.2
Salazar, M.3
Lorente, M.4
Egia, A.5
González-Feria, L.6
Haro, A.7
Velasco, G.8
Guzmán, M.9
-
68
-
-
84906790681
-
Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells
-
Ramer, R.; Fischer, S.; Haustein, M.; Manda, K.; Hinz, B. Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells. Biochem. Pharmacol., 2014, 91(2), 202-216.
-
(2014)
Biochem. Pharmacol
, vol.91
, Issue.2
, pp. 202-216
-
-
Ramer, R.1
Fischer, S.2
Haustein, M.3
Manda, K.4
Hinz, B.5
-
69
-
-
33745250125
-
A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells
-
Kogan, N.M.; Blazquez, C.; Alvarez, L.; Gallily, R.; Schlesinger, M.; Guzman, M.; Mechoulam, R. A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells. Mol. Pharmacol., 2006, 70(1), 51-59.
-
(2006)
Mol. Pharmacol
, vol.70
, Issue.1
, pp. 51-59
-
-
Kogan, N.M.1
Blazquez, C.2
Alvarez, L.3
Gallily, R.4
Schlesinger, M.5
Guzman, M.6
Mechoulam, R.7
-
70
-
-
0028929803
-
Angiogenesis in cancer, vascular, rheumatoid and other disease
-
Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1995, 1(1), 27-30.
-
(1995)
Nat. Med
, vol.1
, Issue.1
, pp. 27-30
-
-
Folkman, J.1
-
71
-
-
0032526098
-
Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells
-
Bisogno, T.; Katayama, K.; Melck, D.; Ueda, N.; De Petrocellis, L.; Yamamoto, S.; Di Marzo, V. Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells. Eur. J. Biochem., 1998, 254(3), 634-642.
-
(1998)
Eur. J. Biochem
, vol.254
, Issue.3
, pp. 634-642
-
-
Bisogno, T.1
Katayama, K.2
Melck, D.3
Ueda, N.4
De Petrocellis, L.5
Yamamoto, S.6
Di Marzo, V.7
-
72
-
-
0033405883
-
Involvement of the camp/protein kinase a pathway and of mitogen-Activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells
-
Melck, D.; Rueda, D.; Galve-Roperh, I.; De Petrocellis, L.; Guzmán, M.; Di Marzo, V. Involvement of the cAMP/protein kinase A pathway and of mitogen-Activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells. FEBS Lett., 1999, 463(3), 235-240.
-
(1999)
FEBS Lett
, vol.463
, Issue.3
, pp. 235-240
-
-
Melck, D.1
Rueda, D.2
Galve-Roperh, I.3
De Petrocellis, L.4
Guzmán, M.5
Di Marzo, V.6
-
73
-
-
0345735671
-
Enhancement of androgen receptor expression induced by (r)-methanandamide in prostate lncap cells
-
Sánchez, M.A.G.; Sánchez, A.M.; Ruiz-Llorente, L.; Daz-Laviada, I. Enhancement of androgen receptor expression induced by (R)-methanandamide in prostate LNCaP cells. FEBS Lett., 2003, 555(3), 561-566.
-
(2003)
FEBS Lett
, vol.555
, Issue.3
, pp. 561-566
-
-
Sánchez, M.A.G.1
Sánchez, A.M.2
Ruiz-Llorente, L.3
Daz-Laviada, I.4
-
74
-
-
1542510624
-
Cannabinoids induce cancer cell proliferation via tumor necrosis factor ?-converting enzyme (tace/adam17)-mediated transactivation of the epidermal growth factor receptor
-
Hart, S.; Fischer, O.M.; Ullrich, A. Cannabinoids induce cancer cell proliferation via tumor necrosis factor ?-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor. Cancer Res., 2004, 64(6), 1943-1950.
-
(2004)
Cancer Res
, vol.64
, Issue.6
, pp. 1943-1950
-
-
Hart, S.1
Fischer, O.M.2
Ullrich, A.3
-
75
-
-
0037365941
-
Inhibition of tumor angiogenesis by cannabinoids
-
Blázquez, C.; Casanova, M.L.; Planas, A.; del Pulgar, T.G.; Villanueva, C.; Fernández-Aceñero, M.J.; Aragonés, J.; Huffman, J.W.; Jorcano, J.L.; Guzmán, M. Inhibition of tumor angiogenesis by cannabinoids. FASEB J., 2003, 17, (3), 529-531.
-
(2003)
FASEB J
, vol.17
, Issue.3
, pp. 529-531
-
-
Blázquez, C.1
Casanova, M.L.2
Planas, A.3
Del Pulgar, T.G.4
Villanueva, C.5
Fernández-Aceñero, M.J.6
Aragonés, J.7
Huffman, J.W.8
Jorcano, J.L.9
Guzmán, M.10
-
76
-
-
77952867838
-
Cannabinoids inhibit cellular respiration of human oral cancer cells
-
Whyte, D.A.; Al-Hammadi, S.; Balhaj, G.; Brown, O.M.; Penefsky, H.S.; Souid, A.-K. Cannabinoids inhibit cellular respiration of human oral cancer cells. Pharmacology, 2010, 85(6), 328-335.
-
(2010)
Pharmacology
, vol.85
, Issue.6
, pp. 328-335
-
-
Whyte, D.A.1
Al-Hammadi, S.2
Balhaj, G.3
Brown, O.M.4
Penefsky, H.S.5
Souid, A.-K.6
-
77
-
-
84864475078
-
Concomitant consumption of marijuana alcohol and tobacco in oral squamous cell carcinoma development and progression: Recent advances and challenges
-
Lopes, C.F.B.; de Angelis, B.B.; Prudente, H.M.; de Souza, B.V.G.; Cardoso, S.V.; de Azambuja Ribeiro, R.I.M. Concomitant consumption of marijuana, alcohol and tobacco in oral squamous cell carcinoma development and progression: recent advances and challenges. Arch. Oral Biol., 2012, 57(8), 1026-1033.
-
(2012)
Arch. Oral Biol
, vol.57
, Issue.8
, pp. 1026-1033
-
-
Lopes, C.F.B.1
De Angelis, B.B.2
Prudente, H.M.3
De Souza, B.V.G.4
Cardoso, S.V.5
De Azambuja Ribeiro, R.I.M.6
-
78
-
-
40549135971
-
Delta 9)-tetrahydrocannabinol inhibits 17?-estradiol-induced proliferation and fails to activate androgen and estrogen receptors in mcf7 human breast cancer cells
-
Von Bueren, A.; Schlumpf, M.; Lichtensteiger, W. Delta (9)-tetrahydrocannabinol inhibits 17?-estradiol-induced proliferation and fails to activate androgen and estrogen receptors in MCF7 human breast cancer cells. Anticancer Res., 2008, 28(1A), 85-89.
-
(2008)
Anticancer Res
, vol.28
, Issue.1 A
, pp. 85-89
-
-
Von Bueren, A.1
Schlumpf, M.2
Lichtensteiger, W.3
-
79
-
-
0034465259
-
Suppression of nerve growth factor trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation 1
-
Melck, D.; De Petrocellis, L.; Orlando, P.; Bisogno, T.; Laezza, C.; Bifulco, M.; Di Marzo, V. Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation 1. Endocrinology, 2000, 141(1), 118-126.
-
(2000)
Endocrinology
, vol.141
, Issue.1
, pp. 118-126
-
-
Melck, D.1
De Petrocellis, L.2
Orlando, P.3
Bisogno, T.4
Laezza, C.5
Bifulco, M.6
Di Marzo, V.7
-
80
-
-
0034672605
-
Serum-dependent effects of tamoxifen and cannabinoids upon c6 glioma cell viability
-
Jacobsson, S.O.; Rongård, E.; Stridh, M.; Tiger, G.; Fowler, C.J. Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability. Biochem. Pharmacol., 2000, 60(12), 1807-1813.
-
(2000)
Biochem. Pharmacol
, vol.60
, Issue.12
, pp. 1807-1813
-
-
Jacobsson, S.O.1
Rongård, E.2
Stridh, M.3
Tiger, G.4
Fowler, C.J.5
-
81
-
-
36749015683
-
Cannabidiol as a novel inhibitor of id-1 gene expression in aggressive breast cancer cells
-
McAllister, S.D.; Christian, R.T.; Horowitz, M.P.; Garcia, A.; Desprez, P.Y. Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells. Mol. Cancer Ther., 2007, 6(11), 2921-2927.
-
(2007)
Mol. Cancer Ther
, vol.6
, Issue.11
, pp. 2921-2927
-
-
McAllister, S.D.1
Christian, R.T.2
Horowitz, M.P.3
Garcia, A.4
Desprez, P.Y.5
-
82
-
-
0037100312
-
Targeting cb2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease
-
McKallip, R.J.; Lombard, C.; Fisher, M.; Martin, B.R.; Ryu, S.; Grant, S.; Nagarkatti, P.S.; Nagarkatti, M. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood, 2002, 100(2), 627-634.
-
(2002)
Blood
, vol.100
, Issue.2
, pp. 627-634
-
-
McKallip, R.J.1
Lombard, C.2
Fisher, M.3
Martin, B.R.4
Ryu, S.5
Grant, S.6
Nagarkatti, P.S.7
Nagarkatti, M.8
-
83
-
-
33746138649
-
Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes
-
Carracedo, A.; Gironella, M.; Lorente, M.; Garcia, S.; Guzmán, M.; Velasco, G.; Iovanna, J.L. Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res., 2006, 66(13), 6748-6755.
-
(2006)
Cancer Res
, vol.66
, Issue.13
, pp. 6748-6755
-
-
Carracedo, A.1
Gironella, M.2
Lorente, M.3
Garcia, S.4
Guzmán, M.5
Velasco, G.6
Iovanna, J.L.7
-
84
-
-
10044248925
-
Marijuana extracts possess the effects like the endocrine disrupting chemicals
-
Watanabe, K.; Motoya, E.; Matsuzawa, N.; Funahashi, T.; Kimura, T.; Matsunaga, T.; Arizono, K.; Yamamoto, I. Marijuana extracts possess the effects like the endocrine disrupting chemicals. Toxicology, 2005, 206(3), 471-478.
-
(2005)
Toxicology
, vol.206
, Issue.3
, pp. 471-478
-
-
Watanabe, K.1
Motoya, E.2
Matsuzawa, N.3
Funahashi, T.4
Kimura, T.5
Matsunaga, T.6
Arizono, K.7
Yamamoto, I.8
-
85
-
-
5044241875
-
Anandamideinduced cell death in primary neuronal cultures: Role of calpain and caspase pathways
-
Movsesyan, V.; Stoica, B.; Yakovlev, A.; Knoblach, S.; Lea, P.t.; Cernak, I.; Vink, R.; Faden, A. Anandamideinduced cell death in primary neuronal cultures: role of calpain and caspase pathways. Cell Death Differ., 2004, 11(10), 1121-1132.
-
(2004)
Cell Death Differ
, vol.11
, Issue.10
, pp. 1121-1132
-
-
Movsesyan, V.1
Stoica, B.2
Yakovlev, A.3
Knoblach, S.4
Lea, P.T.5
Cernak, I.6
Vink, R.7
Faden, A.8
-
86
-
-
73149109062
-
Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis
-
Nomura, D.K.; Long, J.Z.; Niessen, S.; Hoover, H.S.; Ng, S.-W.; Cravatt, B.F. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell, 2010, 140(1), 49-61.
-
(2010)
Cell
, vol.140
, Issue.1
, pp. 49-61
-
-
Nomura, D.K.1
Long, J.Z.2
Niessen, S.3
Hoover, H.S.4
Ng, S.-W.5
Cravatt, B.F.6
-
87
-
-
79960939546
-
Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer
-
Nomura, D.K.; Lombardi, D.P.; Chang, J.W.; Niessen, S.; Ward, A.M.; Long, J.Z.; Hoover, H.H.; Cravatt, B.F. Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer. Chem. Biol., 2011, 18(7), 846-856.
-
(2011)
Chem. Biol
, vol.18
, Issue.7
, pp. 846-856
-
-
Nomura, D.K.1
Lombardi, D.P.2
Chang, J.W.3
Niessen, S.4
Ward, A.M.5
Long, J.Z.6
Hoover, H.H.7
Cravatt, B.F.8
-
88
-
-
10844265493
-
2-Arachidonoylglycerol a novel inhibitor of androgenindependent prostate cancer cell invasion
-
Nithipatikom, K.; Endsley, M.P.; Isbell, M.A.; Falck, J.R.; Iwamoto, Y.; Hillard, C.J.; Campbell, W.B. 2-Arachidonoylglycerol a novel inhibitor of androgenindependent prostate cancer cell invasion. Cancer Res., 2004, 64(24), 8826-8830.
-
(2004)
Cancer Res
, vol.64
, Issue.24
, pp. 8826-8830
-
-
Nithipatikom, K.1
Endsley, M.P.2
Isbell, M.A.3
Falck, J.R.4
Iwamoto, Y.5
Hillard, C.J.6
Campbell, W.B.7
-
89
-
-
49749120682
-
Expression and function of fatty acid amide hydrolase in prostate cancer
-
Endsley, M.P.; Thill, R.; Choudhry, I.; Williams, C.L.; Kajdacsy-? Balla, A.; Campbell, W.B.; Nithipatikom, K. Expression and function of fatty acid amide hydrolase in prostate cancer. Int. J. Cancer, 2008, 123(6), 1318-1326.
-
(2008)
Int. J. Cancer
, vol.123
, Issue.6
, pp. 1318-1326
-
-
Endsley, M.P.1
Thill, R.2
Choudhry, I.3
Williams, C.L.4
Kajdacsy-Balla, A.5
Campbell, W.B.6
Nithipatikom, K.7
-
90
-
-
84938932680
-
Delta-9-?tetrahydrocannabinol and cannabidiol as potential curative agents for cancer. A critical examination of the preclinical literature
-
Fowler, C. Delta-9-?tetrahydrocannabinol and cannabidiol as potential curative agents for cancer. A critical examination of the preclinical literature. Clinc. Pharmacol. Ther., 2015, 97(6), 587-96.
-
(2015)
Clinc. Pharmacol. Ther
, vol.97
, Issue.6
, pp. 587-596
-
-
Fowler, C.1
-
91
-
-
39049104489
-
Cannabinoids for cancer treatment: Progress and promise
-
Sarfaraz, S.; Adhami, V.M.; Syed, D.N.; Afaq, F.; Mukhtar, H. Cannabinoids for cancer treatment: progress and promise. Cancer Res., 2008, 68(2), 339-342.
-
(2008)
Cancer Res
, vol.68
, Issue.2
, pp. 339-342
-
-
Sarfaraz, S.1
Adhami, V.M.2
Syed, D.N.3
Afaq, F.4
Mukhtar, H.5
-
92
-
-
0032586054
-
Delta-9-tetrahydrocannabinol induces apoptosis in human prostate pc-3 cells via a receptor-independent mechanism
-
Ruiz, L.; Miguel, A.; Daz-Laviada, I. Delta-9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism. FEBS Lett., 1999, 458(3), 400-404.
-
(1999)
FEBS Lett
, vol.458
, Issue.3
, pp. 400-404
-
-
Ruiz, L.1
Miguel, A.2
Daz-Laviada, I.3
-
93
-
-
33645763253
-
The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells
-
Carracedo, A.; Lorente, M.; Egia, A.; Blázquez, C.; García, S.; Giroux, V.; Malicet, C.; Villuendas, R.; Gironella, M.; González-Feria, L. The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells. Cancer Cell, 2006, 9(4), 301-312.
-
(2006)
Cancer Cell
, vol.9
, Issue.4
, pp. 301-312
-
-
Carracedo, A.1
Lorente, M.2
Egia, A.3
Blázquez, C.4
García, S.5
Giroux, V.6
Malicet, C.7
Villuendas, R.8
Gironella, M.9
González-Feria, L.10
-
94
-
-
40949083594
-
Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression
-
Blázquez, C.; Salazar, M.; Carracedo, A.; Lorente, M.; Egia, A.; González-Feria, L.; Haro, A.; Velasco, G.; Guzmán, M. Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression. Cancer Res., 2008, 68(6), 1945-1952.
-
(2008)
Cancer Res
, vol.68
, Issue.6
, pp. 1945-1952
-
-
Blázquez, C.1
Salazar, M.2
Carracedo, A.3
Lorente, M.4
Egia, A.5
González-Feria, L.6
Haro, A.7
Velasco, G.8
Guzmán, M.9
-
95
-
-
33745013193
-
Cannabinoids and cancer: Pros and cons of an antitumour strategy
-
Bifulco, M.; Laezza, C.; Pisanti, S.; Gazzerro, P. Cannabinoids and cancer: pros and cons of an antitumour strategy. Br. J. Pharmacol., 2006, 148, (2), 123-135.
-
(2006)
Br. J. Pharmacol
, vol.148
, Issue.2
, pp. 123-135
-
-
Bifulco, M.1
Laezza, C.2
Pisanti, S.3
Gazzerro, P.4
-
96
-
-
34547676475
-
ERBB receptors: From oncogenes to targeted cancer therapies
-
Zhang, H.; Berezov, A.; Wang, Q.; Zhang, G.; Drebin, J.; Murali, R.; Greene, M.I. ErbB receptors: from oncogenes to targeted cancer therapies. J. Clin. Invest., 2007, 117(8), 2051.
-
(2007)
J. Clin. Invest
, vol.117
, Issue.8
, pp. 2051
-
-
Zhang, H.1
Berezov, A.2
Wang, Q.3
Zhang, G.4
Drebin, J.5
Murali, R.6
Greene, M.I.7
-
97
-
-
0036674617
-
Live or let die: The cell's response to p53
-
Vousden, K.H.; Lu, X. Live or let die: the cell's response to p53. Nat. Rev. Cancer, 2002, 2(8), 594-604.
-
(2002)
Nat. Rev. Cancer
, vol.2
, Issue.8
, pp. 594-604
-
-
Vousden, K.H.1
Lu, X.2
-
98
-
-
34250687550
-
The tumour suppressor protein p53, is involved in the activation of the apoptotic cascade by delta-9-tetrahydrocannabinol in cultured cortical neurons
-
Downer, E.J.; Gowran, A.; Murphy, A.C.; Campbell, V.A. The tumour suppressor protein, p53, is involved in the activation of the apoptotic cascade by delta-9-tetrahydrocannabinol in cultured cortical neurons. Eur. J. Pharmacol., 2007, 564(1), 57-65.
-
(2007)
Eur. J. Pharmacol
, vol.564
, Issue.1
, pp. 57-65
-
-
Downer, E.J.1
Gowran, A.2
Murphy, A.C.3
Campbell, V.A.4
-
99
-
-
66449115318
-
Cannabinoid action induces autophagy-mediated cell death through stimulation of er stress in human glioma cells
-
Salazar, M.; Carracedo, A.; Salanueva, I.J.; Hernández-Tiedra, S.; Lorente, M.; Egia, A.; Vázquez, P.; Blázquez, C.; Torres, S.; García, S. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J. Clin. Invest., 2009, 119(5), 1359.
-
(2009)
J. Clin. Invest
, vol.119
, Issue.5
, pp. 1359
-
-
Salazar, M.1
Carracedo, A.2
Salanueva, I.J.3
Hernández-Tiedra, S.4
Lorente, M.5
Egia, A.6
Vázquez, P.7
Blázquez, C.8
Torres, S.9
García, S.10
-
100
-
-
83855160816
-
Cannabinoids endocannabinoids, and cancer
-
Hermanson, D.J.; Marnett, L.J. Cannabinoids, endocannabinoids, and cancer. Cancer Metastasis Rev., 2011, 30(3-4), 599-612.
-
(2011)
Cancer Metastasis Rev
, vol.30
, Issue.3-4
, pp. 599-612
-
-
Hermanson, D.J.1
Marnett, L.J.2
-
101
-
-
79958809001
-
Anti-tumoral action of cannabinoids on hepatocellular carcinoma: Role of ampkdependent activation of autophagy
-
Vara, D.; Salazar, M.; Olea-Herrero, N.; Guzmán, M.; Velasco, G.; Díaz-Laviada, I. Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPKdependent activation of autophagy. Cell Death Differ., 2011, 18(7), 1099-1111.
-
(2011)
Cell Death Differ
, vol.18
, Issue.7
, pp. 1099-1111
-
-
Vara, D.1
Salazar, M.2
Olea-Herrero, N.3
Guzmán, M.4
Velasco, G.5
Díaz-Laviada, I.6
-
102
-
-
84875487849
-
Inductions of the fatty acid 2-hydroxylase (fa2h) gene by delta-9-tetrahydrocannabinol in human breast cancer cells
-
Takeda, S.; Harada, M.; Su, S.; Okajima, S.; Miyoshi, H.; Yoshida, K.; Nishimura, H.; Okamoto, Y.; Amamoto, T.; Watanabe, K. Inductions of the fatty acid 2-hydroxylase (FA2H) gene by delta-9-tetrahydrocannabinol in human breast cancer cells. J. Toxicol. Sci., 2013, 38(2), 305.
-
(2013)
J. Toxicol. Sci
, vol.38
, Issue.2
, pp. 305
-
-
Takeda, S.1
Harada, M.2
Su, S.3
Okajima, S.4
Miyoshi, H.5
Yoshida, K.6
Nishimura, H.7
Okamoto, Y.8
Amamoto, T.9
Watanabe, K.10
-
103
-
-
84907557918
-
Down-regulation of cyclooxygenase-2 (cox-2) by cannabidiolic acid in human breast cancer cells
-
Takeda, S.; Okazaki, H.; Ikeda, E.; Abe, S.; Yoshioka, Y.; Watanabe, K.; Aramaki, H. Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells. J. Toxicol. Sci, 2014, 39(5), 711-716.
-
(2014)
J. Toxicol. Sci
, vol.39
, Issue.5
, pp. 711-716
-
-
Takeda, S.1
Okazaki, H.2
Ikeda, E.3
Abe, S.4
Yoshioka, Y.5
Watanabe, K.6
Aramaki, H.7
-
104
-
-
78751527443
-
A combined preclinical therapy of cannabinoids and temozolomide against glioma
-
Torres, S.; Lorente, M.; Rodríguez-Fornés, F.; Hernández-Tiedra, S.; Salazar, M.; García-Taboada, E.; Barcia, J.; Guzmán, M.; Velasco, G. A combined preclinical therapy of cannabinoids and temozolomide against glioma. Mol. Cancer Ther., 2011, 10(1), 90-103.
-
(2011)
Mol. Cancer Ther
, vol.10
, Issue.1
, pp. 90-103
-
-
Torres, S.1
Lorente, M.2
Rodríguez-Fornés, F.3
Hernández-Tiedra, S.4
Salazar, M.5
García-Taboada, E.6
Barcia, J.7
Guzmán, M.8
Velasco, G.9
-
105
-
-
84872555149
-
Non-?thc cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: Pro-?apoptotic effects and underlying mechanisms
-
De Petrocellis, L.; Ligresti, A.; Schiano Moriello, A.; Iappelli, M.; Verde, R.; Stott, C.G.; Cristino, L.; Orlando, P.; Di Marzo, V. Non-?THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-?apoptotic effects and underlying mechanisms. Br. J. Pharmacol., 2013, 168(1), 79-102.
-
(2013)
Br. J. Pharmacol
, vol.168
, Issue.1
, pp. 79-102
-
-
De Petrocellis, L.1
Ligresti, A.2
Schiano Moriello, A.3
Iappelli, M.4
Verde, R.5
Stott, C.G.6
Cristino, L.7
Orlando, P.8
Di Marzo, V.9
-
106
-
-
84917737275
-
The combination of cannabidiol and delta-9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model
-
Scott, K.A.; Dalgleish, A.G.; Liu, W.M. The combination of cannabidiol and delta-9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model. Mol. Cancer Ther., 2014, 13(12), 2955-2967.
-
(2014)
Mol. Cancer Ther
, vol.13
, Issue.12
, pp. 2955-2967
-
-
Scott, K.A.1
Dalgleish, A.G.2
Liu, W.M.3
-
107
-
-
84938096558
-
Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death
-
Armstrong, J.L.; Hill, D.S.; McKee, C.S.; Hernandez-Tiedra, S.; Lorente, M.; Lopez-Valero, I.; Anagnostou, M.E.; Babatunde, F.; Corazzari, M.; Redfern, C.P. Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death. J. Invest. Dermatol., 2015, 135(6), 1629-37.
-
(2015)
J. Invest. Dermatol
, vol.135
, Issue.6
, pp. 1629-1637
-
-
Armstrong, J.L.1
Hill, D.S.2
McKee, C.S.3
Hernandez-Tiedra, S.4
Lorente, M.5
Lopez-Valero, I.6
Anagnostou, M.E.7
Babatunde, F.8
Corazzari, M.9
Redfern, C.P.10
-
108
-
-
35648934575
-
Meta-?analysis of cannabinoid ligand binding affinity and receptor distribution: Interspecies differences
-
McPartland, J.; Glass, M.; Pertwee, R. Meta-?analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences. Br. J. Pharmacol., 2007, 152(5), 583-593.
-
(2007)
Br. J. Pharmacol
, vol.152
, Issue.5
, pp. 583-593
-
-
McPartland, J.1
Glass, M.2
Pertwee, R.3
-
109
-
-
33645851325
-
Randomized doubleblind placebo-controlled study about the effects of cannabidiol (cbd) on the pharmacokinetics of delta-9-tetrahydrocannabinol (thc) after oral application of thc verses standardized cannabis extract
-
Nadulski, T.; Pragst, F.; Weinberg, G.; Roser, P.; Schnelle, M.; Fronk, E.-M.; Stadelmann, A.M. Randomized, doubleblind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of delta-9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract. Ther. Drug Monit., 2005, 27(6), 799-810.
-
(2005)
Ther. Drug Monit
, vol.27
, Issue.6
, pp. 799-810
-
-
Nadulski, T.1
Pragst, F.2
Weinberg, G.3
Roser, P.4
Schnelle, M.5
Fronk, E.-M.6
Stadelmann, A.M.7
-
110
-
-
34548510337
-
Human cannabinoid pharmacokinetics
-
Huestis, M.A. Human cannabinoid pharmacokinetics. Chem. Biodivers., 2007, 4(8), 1770-1804.
-
(2007)
Chem. Biodivers
, vol.4
, Issue.8
, pp. 1770-1804
-
-
Huestis, M.A.1
-
111
-
-
84859438323
-
The valley of death in anticancer drug development: A reassessment
-
Adams, D.J. The Valley of death in anticancer drug development: a reassessment. Trends Pharmacol. Sci. 2012, 33(4), 173-180.
-
(2012)
Trends Pharmacol. Sci
, vol.33
, Issue.4
, pp. 173-180
-
-
Adams, D.J.1
-
112
-
-
84886873610
-
Cannabidiol a non-psychoactive cannabinoid compound inhibits proliferation and invasion in u87-mg and t98g glioma cells through a multitarget effect
-
Solinas, M.; Massi, P.; Cinquina, V.; Valenti, M.; Bolognini, D.; Gariboldi, M.; Monti, E.; Rubino, T.; Parolaro, D. Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect. PLoS One, 2013, 8(10), e76918.
-
(2013)
PLoS One
, vol.8
, Issue.10
, pp. e76918
-
-
Solinas, M.1
Massi, P.2
Cinquina, V.3
Valenti, M.4
Bolognini, D.5
Gariboldi, M.6
Monti, E.7
Rubino, T.8
Parolaro, D.9
-
113
-
-
84902540119
-
Physiological intestinal oxygen modulates the caco-2 cell model and increases sensitivity to the phytocannabinoid cannabidiol
-
Macpherson, T.; Armstrong, J.A.; Criddle, D.N.; Wright, K.L. Physiological intestinal oxygen modulates the Caco-2 cell model and increases sensitivity to the phytocannabinoid cannabidiol. In Vitro Cell. Develop. Biol.-Anim., 2014, 50(5), 417-426.
-
(2014)
Vitro Cell. Develop. Biol.-Anim
, vol.50
, Issue.5
, pp. 417-426
-
-
Macpherson, T.1
Armstrong, J.A.2
Criddle, D.N.3
Wright, K.L.4
-
114
-
-
65649125934
-
Cannabidiol in medicine: A review of its therapeutic potential in cns disorders
-
Scuderi, C.; Filippis, D.D.; Iuvone, T.; Blasio, A.; Steardo, A.; Esposito, G. Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders. Phytother. Res., 2009, 23, (5), 597-602.
-
(2009)
Phytother. Res
, vol.23
, Issue.5
, pp. 597-602
-
-
Scuderi, C.1
Filippis, D.D.2
Iuvone, T.3
Blasio, A.4
Steardo, A.5
Esposito, G.6
-
115
-
-
84908394165
-
Cannabidiol promise and pitfalls
-
Welty, T.E.; Luebke, A.; Gidal, B.E. Cannabidiol: Promise and Pitfalls. Epilepsy Curr., 2014, 14(5), 250-252.
-
(2014)
Epilepsy Curr
, vol.14
, Issue.5
, pp. 250-252
-
-
Welty, T.E.1
Luebke, A.2
Gidal, B.E.3
-
116
-
-
0013768939
-
Hashish-i the structure of cannabidiol
-
Mechoulam, R.; Shvo, Y. Hashish-I: the structure of cannabidiol. Tetrahedron, 1963, 19(12), 2073-2078.
-
(1963)
Tetrahedron
, vol.19
, Issue.12
, pp. 2073-2078
-
-
Mechoulam, R.1
Shvo, Y.2
-
117
-
-
33847653702
-
Cannabidiol displays unexpectedly high potency as an antagonist of cb1 and cb2 receptor agonists in vitro
-
Thomas, A.; Baillie, G.; Phillips, A.; Razdan, R.; Ross, R.; Pertwee, R. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. Br. J. Pharmacol., 2007, 150(5), 613-623.
-
(2007)
Br. J. Pharmacol
, vol.150
, Issue.5
, pp. 613-623
-
-
Thomas, A.1
Baillie, G.2
Phillips, A.3
Razdan, R.4
Ross, R.5
Pertwee, R.6
-
118
-
-
84872233704
-
Cannabidiol as potential anticancer drug
-
Massi, P.; Solinas, M.; Cinquina, V.; Parolaro, D. Cannabidiol as potential anticancer drug. Br. J. Clin. Pharmacol., 2013, 75(2), 303-312.
-
(2013)
Br. J. Clin. Pharmacol
, vol.75
, Issue.2
, pp. 303-312
-
-
Massi, P.1
Solinas, M.2
Cinquina, V.3
Parolaro, D.4
-
119
-
-
0036019382
-
Cannabinoid receptors and their ligands
-
Pertwee, R.; Ross, R. Cannabinoid receptors and their ligands. Prostaglandins, Leukotrienes Essential Fatty Acids, 2002, 66(2), 101-121.
-
(2002)
Prostaglandins Leukotrienes Essential Fatty Acids
, vol.66
, Issue.2
, pp. 101-121
-
-
Pertwee, R.1
Ross, R.2
-
120
-
-
79960328574
-
Effects of cannabinoids and cannabinoid-?enriched cannabis extracts on trp channels and endocannabinoid metabolic enzymes
-
De Petrocellis, L.; Ligresti, A.; Moriello, A.S.; Allarà, M.; Bisogno, T.; Petrosino, S.; Stott, C.G.; Di Marzo, V. Effects of cannabinoids and cannabinoid-?enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br. J. Pharmacol., 2011, 163(7), 1479-1494.
-
(2011)
Br. J. Pharmacol
, vol.163
, Issue.7
, pp. 1479-1494
-
-
De Petrocellis, L.1
Ligresti, A.2
Moriello, A.S.3
Allarà, M.4
Bisogno, T.5
Petrosino, S.6
Stott, C.G.7
Di Marzo, V.8
-
121
-
-
33646734889
-
Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression
-
Carrier, E.J.; Auchampach, J.A.; Hillard, C.J. Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proc. Natl. Acad. Sci. USA, 2006, 103(20), 7895-7900.
-
(2006)
Proc. Natl. Acad. Sci. USA
, vol.103
, Issue.20
, pp. 7895-7900
-
-
Carrier, E.J.1
Auchampach, J.A.2
Hillard, C.J.3
-
122
-
-
0034053334
-
Membrane associated antitumor effects of crocine-, ginsenoside-And cannabinoid derivates
-
Molnar, J.; Szabo, D.; Pusztai, R.; Mucsi, I.; Berek, L.; Ocsovszki, I.; Kawata, E.; Shoyama, Y. Membrane associated antitumor effects of crocine-, ginsenoside-And cannabinoid derivates. Anticancer Res., 1999, 20(2A), 861-867.
-
(1999)
Anticancer Res
, vol.20
, Issue.2 A
, pp. 861-867
-
-
Molnar, J.1
Szabo, D.2
Pusztai, R.3
Mucsi, I.4
Berek, L.5
Ocsovszki, I.6
Kawata, E.7
Shoyama, Y.8
-
123
-
-
33644828740
-
The effects of cannabinoids on p-glycoprotein transport and expression in multidrug resistant cells
-
Holland, M.; Panetta, J.; Hoskins, J.; Bebawy, M.; Roufogalis, B.; Allen, J.; Arnold, J. The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells. Biochem. Pharmacol., 2006, 71(8), 1146-1154.
-
(2006)
Biochem. Pharmacol
, vol.71
, Issue.8
, pp. 1146-1154
-
-
Holland, M.1
Panetta, J.2
Hoskins, J.3
Bebawy, M.4
Roufogalis, B.5
Allen, J.6
Arnold, J.7
-
124
-
-
33645841349
-
Characterization of p-glycoprotein inhibition by major cannabinoids from marijuana
-
Zhu, H.-J.; Wang, J.S.; Markowitz, J.S.; Donovan, J.L.; Gibson, B.B.; Gefroh, H.A.; DeVane, C.L. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana. J. Pharmacol. Exp. Ther. 2006, 317(2), 850-857.
-
(2006)
J. Pharmacol. Exp. Ther
, vol.317
, Issue.2
, pp. 850-857
-
-
Zhu, H.-J.1
Wang, J.S.2
Markowitz, J.S.3
Donovan, J.L.4
Gibson, B.B.5
Gefroh, H.A.6
DeVane, C.L.7
-
125
-
-
84885142404
-
Cannabidiol changes p-gp and bcrp expression in trophoblast cell lines
-
Feinshtein, V.; Erez, O.; Ben-Zvi, Z.; Erez, N.; Eshkoli, T.; Sheizaf, B.; Sheiner, E.; Huleihel, M.; Holcberg, G. Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines. Peer J., 2013, 1, e153.
-
(2013)
Peer J
, vol.1
, pp. e153
-
-
Feinshtein, V.1
Erez, O.2
Ben-Zvi, Z.3
Erez, N.4
Eshkoli, T.5
Sheizaf, B.6
Sheiner, E.7
Huleihel, M.8
Holcberg, G.9
-
126
-
-
35648948415
-
The multidrug transporter abcg2 (bcrp) is inhibited by plant-?derived cannabinoids
-
Holland, M.; Lau, D.; Allen, J.; Arnold, J. The multidrug transporter ABCG2 (BCRP) is inhibited by plant-?derived cannabinoids. Br. J. Pharmacol., 2007, 152(5), 815-824.
-
(2007)
Br. J. Pharmacol
, vol.152
, Issue.5
, pp. 815-824
-
-
Holland, M.1
Lau, D.2
Allen, J.3
Arnold, J.4
-
127
-
-
84921602739
-
New insights into antimetastatic and antiangiogenic effects of cannabinoids
-
Ramer, R.; Hinz, B. New insights into antimetastatic and antiangiogenic effects of cannabinoids. Int. Rev. Cell Mol. Biol., 2015, 314, 43-116.
-
(2015)
Int. Rev. Cell Mol. Biol
, vol.314
, pp. 43-116
-
-
Ramer, R.1
Hinz, B.2
-
128
-
-
0032519371
-
Enhanced cytolytic activity of tumor infiltrating lymphocytes (tils) derived from an icam-1 transfected tumor in a murine model
-
Lefor, A.T.; Fabian, D.F. Enhanced cytolytic activity of tumor infiltrating lymphocytes (TILs) derived from an ICAM-1 transfected tumor in a murine model. J. Surg. Res., 1998, 75(1), 49-53.
-
(1998)
J. Surg. Res
, vol.75
, Issue.1
, pp. 49-53
-
-
Lefor, A.T.1
Fabian, D.F.2
-
129
-
-
0029151840
-
Enhanced expression of icam-1 in a murine fibrosarcoma reduces tumor growth rate
-
Sartor, W.M.; Kyprianou, N.; Fabian, D.F.; Lefor, A.T. Enhanced expression of ICAM-1 in a murine fibrosarcoma reduces tumor growth rate. J. Surg. Res., 1995, 59(1), 66-74.
-
(1995)
J. Surg. Res
, vol.59
, Issue.1
, pp. 66-74
-
-
Sartor, W.M.1
Kyprianou, N.2
Fabian, D.F.3
Lefor, A.T.4
-
130
-
-
0027104015
-
Human colon cancer cells express icam-1 in vivo and support lfa-1-dependent lymphocyte adhesion in vitro
-
Kelly, C.; O'keane, J.; Orellana, J.; Schroy, P.; Yang, S.; LaMont, J.; Brady, H. Human colon cancer cells express ICAM-1 in vivo and support LFA-1-dependent lymphocyte adhesion in vitro. Am. J. Physiol., 1992, 263(6), G864-G870.
-
(1992)
Am. J. Physiol
, vol.263
, Issue.6
, pp. G864-G870
-
-
Kelly, C.1
O'Keane, J.2
Orellana, J.3
Schroy, P.4
Yang, S.5
LaMont, J.6
Brady, H.7
-
131
-
-
0025138331
-
Expression of the adhesion molecule icam-1 and major histocompatibility complex class i antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro
-
Vanky, F.; Wang, P.; Patarroyo, M.; Klein, E. Expression of the adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro. Cancer Immunol., 1990, 31(1), 19-27.
-
(1990)
Cancer Immunol
, vol.31
, Issue.1
, pp. 19-27
-
-
Vanky, F.1
Wang, P.2
Patarroyo, M.3
Klein, E.4
-
132
-
-
0036580775
-
Expression of intercellular adhesion molecule-1 and prognosis in colorectal cancer
-
Maeda, K.; Kang, S.M.; Sawada, T.; Nishiguchi, Y.; Yashiro, M.; Ogawa, Y.; Ohira, M.; Ishikawa, T.; Hirakawa-YS Chung, K. Expression of intercellular adhesion molecule-1 and prognosis in colorectal cancer. Oncol. Rep., 2002, 9(3), 511-514.
-
(2002)
Oncol. Rep
, vol.9
, Issue.3
, pp. 511-514
-
-
Maeda, K.1
Kang, S.M.2
Sawada, T.3
Nishiguchi, Y.4
Yashiro, M.5
Ogawa, Y.6
Ohira, M.7
Ishikawa, T.8
Hirakawa, Y.S.9
Chung, K.10
-
133
-
-
0031929989
-
Expression of intercellular adhesion molecule-1 in invasive breast cancer reflects low growth potential negative lymph node involvement, and good prognosis
-
Ogawa, Y.; Hirakawa, K.; Nakata, B.; Fujihara, T.; Sawada, T.; Kato, Y.; Yoshikawa, K.; Sowa, M. Expression of intercellular adhesion molecule-1 in invasive breast cancer reflects low growth potential, negative lymph node involvement, and good prognosis. Clin. Cancer Res., 1998, 4(1), 31-36.
-
(1998)
Clin. Cancer Res
, vol.4
, Issue.1
, pp. 31-36
-
-
Ogawa, Y.1
Hirakawa, K.2
Nakata, B.3
Fujihara, T.4
Sawada, T.5
Kato, Y.6
Yoshikawa, K.7
Sowa, M.8
-
134
-
-
84908355024
-
Cannabinoids increase lung cancer cell lysis by lymphokine-Activated killer cells via upregulation of icam-1
-
Haustein, M.; Ramer, R.; Linnebacher, M.; Manda, K.; Hinz, B. Cannabinoids increase lung cancer cell lysis by lymphokine-Activated killer cells via upregulation of ICAM-1. Biochem. Pharmacol., 2014, 92(2), 312-325.
-
(2014)
Biochem. Pharmacol
, vol.92
, Issue.2
, pp. 312-325
-
-
Haustein, M.1
Ramer, R.2
Linnebacher, M.3
Manda, K.4
Hinz, B.5
-
135
-
-
76749083341
-
Antitumorigenic effects of cannabinoids beyond apoptosis
-
Freimuth, N.; Ramer, R.; Hinz, B. Antitumorigenic effects of cannabinoids beyond apoptosis. J. Pharmacol. Exp. Ther., 2010, 332(2), 336-344.
-
(2010)
J. Pharmacol. Exp. Ther
, vol.332
, Issue.2
, pp. 336-344
-
-
Freimuth, N.1
Ramer, R.2
Hinz, B.3
-
136
-
-
85039813575
-
-
Valenti, M.; Massi, P.; Bolognini, D.; Solinas, M.; Parolaro, D. In Il Valore del Farmaco per la Tutela della Salute, 2009.
-
(2009)
Il Valore Del Farmaco per la Tutela della Salute
-
-
Valenti, M.1
Massi, P.2
Bolognini, D.3
Solinas, M.4
Parolaro, D.5
-
137
-
-
84874840668
-
Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target
-
Soroceanu, L.; Murase, R.; Limbad, C.; Singer, E.; Allison, J.; Adrados, I.; Kawamura, R.; Pakdel, A.; Fukuyo, Y.; Nguyen, D. Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target. Cancer Res., 2013, 73(5), 1559-1569.
-
(2013)
Cancer Res
, vol.73
, Issue.5
, pp. 1559-1569
-
-
Soroceanu, L.1
Murase, R.2
Limbad, C.3
Singer, E.4
Allison, J.5
Adrados, I.6
Kawamura, R.7
Pakdel, A.8
Fukuyo, Y.9
Nguyen, D.10
-
138
-
-
84927667530
-
Targeting multiple cannabinoid anti-?tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer
-
Murase, R.; Kawamura, R.; Singer, E.; Pakdel, A.; Sarma, P.; Judkins, J.; Elwakeel, E.; Dayal, S.; Martinez-?Martinez, E.; Amere, M. Targeting multiple cannabinoid anti-?tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer. Br. J. Pharmacol., 2014, 171(19), 4464-4477.
-
(2014)
Br. J. Pharmacol
, vol.171
, Issue.19
, pp. 4464-4477
-
-
Murase, R.1
Kawamura, R.2
Singer, E.3
Pakdel, A.4
Sarma, P.5
Judkins, J.6
Elwakeel, E.7
Dayal, S.8
Martinez-Martinez, E.9
Amere, M.10
-
139
-
-
79960835512
-
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation invasion, and metastasis
-
McAllister, S.D.; Murase, R.; Christian, R.T.; Lau, D.; Zielinski, A.J.; Allison, J.; Almanza, C.; Pakdel, A.; Lee, J.; Limbad, C. Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. Breast Cancer Res. Treat., 2011, 129(1), 37-47.
-
(2011)
Breast Cancer Res. Treat
, vol.129
, Issue.1
, pp. 37-47
-
-
McAllister, S.D.1
Murase, R.2
Christian, R.T.3
Lau, D.4
Zielinski, A.J.5
Allison, J.6
Almanza, C.7
Pakdel, A.8
Lee, J.9
Limbad, C.10
-
140
-
-
34548185155
-
Upregulation of tissue inhibitor of matrix metalloproteinases-1 confers the antiinvasive action of cisplatin on human cancer cells
-
Ramer, R.; Eichele, K.; Hinz, B. Upregulation of tissue inhibitor of matrix metalloproteinases-1 confers the antiinvasive action of cisplatin on human cancer cells. Oncogene, 2007, 26,(39), 5822-5827.
-
(2007)
Oncogene
, vol.26
, Issue.39
, pp. 5822-5827
-
-
Ramer, R.1
Eichele, K.2
Hinz, B.3
-
141
-
-
33748492117
-
The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells
-
Massi, P.; Vaccani, A.; Bianchessi, S.; Costa, B.; Macchi, P.; Parolaro, D. The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells. Cell Mol. Life Sci. CMLS, 2006, 63(17), 2057-2066.
-
(2006)
Cell Mol. Life Sci. CMLS
, vol.63
, Issue.17
, pp. 2057-2066
-
-
Massi, P.1
Vaccani, A.2
Bianchessi, S.3
Costa, B.4
Macchi, P.5
Parolaro, D.6
-
142
-
-
0141758489
-
Irradiation enhances apoptosis induced by cannabidiol, a non-psychotropic cannabinoid, in cultured hl-60 myeloblastic leukemia cells
-
Gallily, R.; Even-Chen, T.; Katzavian, G.; Lehmann, D.; Dagan, A.; Mechoulam, R. ?-Irradiation enhances apoptosis induced by cannabidiol, a non-psychotropic cannabinoid, in cultured HL-60 myeloblastic leukemia cells. Leukemia Lymphoma, 2003, 44(10), 1767-1773.
-
(2003)
Leukemia Lymphoma
, vol.44
, Issue.10
, pp. 1767-1773
-
-
Gallily, R.1
Even-Chen, T.2
Katzavian, G.3
Lehmann, D.4
Dagan, A.5
Mechoulam, R.6
-
143
-
-
33747592582
-
Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and nox4 expression
-
McKallip, R.J.; Jia, W.; Schlomer, J.; Warren, J.W.; Nagarkatti, P.S.; Nagarkatti, M. Cannabidiol-induced apoptosis in human leukemia cells: a novel role of cannabidiol in the regulation of p22phox and Nox4 expression. Mol. Pharmacol., 2006, 70(3), 897-908.
-
(2006)
Mol. Pharmacol
, vol.70
, Issue.3
, pp. 897-908
-
-
McKallip, R.J.1
Jia, W.2
Schlomer, J.3
Warren, J.W.4
Nagarkatti, P.S.5
Nagarkatti, M.6
-
144
-
-
57749089665
-
Caspase-mediated cleavage of atg6/beclin-1 links apoptosis to autophagy in hela cells
-
Cho, D.H.; Jo, Y.K.; Hwang, J.J.; Lee, Y.M.; Roh, S.A.; Kim, J.C. Caspase-mediated cleavage of ATG6/Beclin-1 links apoptosis to autophagy in HeLa cells. Cancer Lett., 2009, 274(1), 95-100.
-
(2009)
Cancer Lett
, vol.274
, Issue.1
, pp. 95-100
-
-
Cho, D.H.1
Jo, Y.K.2
Hwang, J.J.3
Lee, Y.M.4
Roh, S.A.5
Kim, J.C.6
-
145
-
-
78649636176
-
Caspase-mediated cleavage of beclin-1 inactivates beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria
-
Wirawan, E.; Walle, L.V.; Kersse, K.; Cornelis, S.; Claerhout, S.; Vanoverberghe, I.; Roelandt, R.; De Rycke, R.; Verspurten, J.; Declercq, W. Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis., 2010, 1(1), e18.
-
(2010)
Cell Death Dis
, vol.1
, Issue.1
, pp. e18
-
-
Wirawan, E.1
Walle, L.V.2
Kersse, K.3
Cornelis, S.4
Claerhout, S.5
Vanoverberghe, I.6
Roelandt, R.7
De Rycke, R.8
Verspurten, J.9
Declercq, W.10
-
146
-
-
79960115996
-
Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy
-
Shrivastava, A.; Kuzontkoski, P.M.; Groopman, J.E.; Prasad, A. Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy. Mol. Cancer Ther., 2011, 10(7), 1161-1172.
-
(2011)
Mol. Cancer Ther
, vol.10
, Issue.7
, pp. 1161-1172
-
-
Shrivastava, A.1
Kuzontkoski, P.M.2
Groopman, J.E.3
Prasad, A.4
-
147
-
-
84926410281
-
Modulation of the tumor microenvironment and inhibition of egf/EGFR pathway; Novel anti-tumor mechanisms of cannabidiol in breast cancer
-
Elbaz, M.; Nasser, M.W.; Ravi, J.; Wani, N.A.; Ahirwar, D.K.; Zhao, H.; Oghumu, S.; Satoskar, A.R.; Shilo, K.; Carson, W.E. Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway; novel anti-tumor mechanisms of Cannabidiol in breast cancer. Mol. Oncol., 2015, 9(4), 906-16.
-
(2015)
Mol. Oncol
, vol.9
, Issue.4
, pp. 906-916
-
-
Elbaz, M.1
Nasser, M.W.2
Ravi, J.3
Wani, N.A.4
Ahirwar, D.K.5
Zhao, H.6
Oghumu, S.7
Satoskar, A.R.8
Shilo, K.9
Carson, W.E.10
-
148
-
-
38449109178
-
5-?Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-?psychoactive cannabinoid
-
Massi, P.; Valenti, M.; Vaccani, A.; Gasperi, V.; Perletti, G.; Marras, E.; Fezza, F.; Maccarrone, M.; Parolaro, D. 5-?Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-?psychoactive cannabinoid. J. Neurochem., 2008, 104(4), 1091-1100.
-
(2008)
J. Neurochem
, vol.104
, Issue.4
, pp. 1091-1100
-
-
Massi, P.1
Valenti, M.2
Vaccani, A.3
Gasperi, V.4
Perletti, G.5
Marras, E.6
Fezza, F.7
Maccarrone, M.8
Parolaro, D.9
-
149
-
-
41149153235
-
A comparative study on cannabidiol-induced apoptosis in murine thymocytes and el-4 thymoma cells
-
Lee, C.Y.; Wey, S.P.; Liao, M.H.; Hsu, W.-L.; Wu, H.-Y.; Jan, T.-R. A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells. : Int. Immunopharmacol., 2008, 8(5), 732-740.
-
(2008)
Int. Immunopharmacol
, vol.8
, Issue.5
, pp. 732-740
-
-
Lee, C.Y.1
Wey, S.P.2
Liao, M.H.3
Hsu, W.-L.4
Wu, H.-Y.5
Jan, T.-R.6
-
150
-
-
84896391802
-
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-?2
-
Morelli, M.B.; Offidani, M.; Alesiani, F.; Discepoli, G.; Liberati, S.; Olivieri, A.; Santoni, M.; Santoni, G.; Leoni, P.; Nabissi, M. The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-?2. Int. J. Cancer, 2014, 134(11), 2534-2546.
-
(2014)
Int. J. Cancer
, vol.134
, Issue.11
, pp. 2534-2546
-
-
Morelli, M.B.1
Offidani, M.2
Alesiani, F.3
Discepoli, G.4
Liberati, S.5
Olivieri, A.6
Santoni, M.7
Santoni, G.8
Leoni, P.9
Nabissi, M.10
-
151
-
-
84865124829
-
Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer
-
Aviello, G.; Romano, B.; Borrelli, F.; Capasso, R.; Gallo, L.; Piscitelli, F.; Di Marzo, V.; Izzo, A.A. Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer. J. Mol Med., 2012, 90(8), 925-934.
-
(2012)
J. Mol Med
, vol.90
, Issue.8
, pp. 925-934
-
-
Aviello, G.1
Romano, B.2
Borrelli, F.3
Capasso, R.4
Gallo, L.5
Piscitelli, F.6
Di Marzo, V.7
Izzo, A.A.8
-
152
-
-
84898058079
-
Inhibition of colon carcinogenesis by a standardized cannabis sativa extract with high content of cannabidiol
-
Romano, B.; Borrelli, F.; Pagano, E.; Cascio, M.G.; Pertwee, R.G.; Izzo, A.A. Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol. Phytomedicine, 2014, 21(5), 631-639.
-
(2014)
Phytomedicine
, vol.21
, Issue.5
, pp. 631-639
-
-
Romano, B.1
Borrelli, F.2
Pagano, E.3
Cascio, M.G.4
Pertwee, R.G.5
Izzo, A.A.6
-
153
-
-
84872912661
-
Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme
-
de la Ossa, D.H.P.; Lorente, M.; Gil-Alegre, M.E.; Torres, S.; García-Taboada, E.; del Rosario Aberturas, M.; Molpeceres, J.; Velasco, G.; Torres-Suarez, A.I. Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme. PLoS One, 2013, 8(1), e54795.
-
(2013)
PLoS One
, vol.8
, Issue.1
, pp. e54795
-
-
De La Ossa, D.H.P.1
Lorente, M.2
Gil-Alegre, M.E.3
Torres, S.4
García-Taboada, E.5
Del Rosario Aberturas, M.6
Molpeceres, J.7
Velasco, G.8
Torres-Suarez, A.I.9
-
154
-
-
84923611271
-
Colon carcinogenesis is inhibited by the trpm8 antagonist cannabigerol, a cannabis-derived nonpsychotropic cannabinoid
-
Borrelli, F.; Pagano, E.; Romano, B.; Panzera, S.; Maiello, F.; Coppola, D.; De Petrocellis, L.; Buono, L.; Orlando, P.; Izzo, A.A. Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived nonpsychotropic cannabinoid. Carcinogenesis, 2014, 35(12), 2787-97.
-
(2014)
Carcinogenesis
, vol.35
, Issue.12
, pp. 2787-2797
-
-
Borrelli, F.1
Pagano, E.2
Romano, B.3
Panzera, S.4
Maiello, F.5
Coppola, D.6
De Petrocellis, L.7
Buono, L.8
Orlando, P.9
Izzo, A.A.10
-
155
-
-
84867129187
-
Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of mdamb-231 breast cancer cell migration
-
Takeda, S.; Okajima, S.; Miyoshi, H.; Yoshida, K.; Okamoto, Y.; Okada, T.; Amamoto, T.; Watanabe, K.; Omiecinski, C.J.; Aramaki, H. Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDAMB-231 breast cancer cell migration. Toxicol. Lett, 2012, 214(3), 314-319.
-
(2012)
Toxicol. Lett
, vol.214
, Issue.3
, pp. 314-319
-
-
Takeda, S.1
Okajima, S.2
Miyoshi, H.3
Yoshida, K.4
Okamoto, Y.5
Okada, T.6
Amamoto, T.7
Watanabe, K.8
Omiecinski, C.J.9
Aramaki, H.10
-
156
-
-
84863795263
-
Betulinic acid targets yy1 and erbb2 through cannabinoid receptor-dependent disruption of microrna-27a: Zbtb10 in breast cancer
-
Liu, X.; Jutooru, I.; Lei, P.; Kim, K.; Lee, S.O.; Brents, L.K.; Prather, P.L.; Safe, S. Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a: ZBTB10 in breast cancer. Mol. Cancer Ther., 2012, 11(7), 1421-1431.
-
(2012)
Mol. Cancer Ther
, vol.11
, Issue.7
, pp. 1421-1431
-
-
Liu, X.1
Jutooru, I.2
Lei, P.3
Kim, K.4
Lee, S.O.5
Brents, L.K.6
Prather, P.L.7
Safe, S.8
-
157
-
-
84921449688
-
Bisdemethoxycurcumin induces apoptosis in activated hepatic stellate cells via cannabinoid receptor 2
-
Lee, P.J.; Woo, S.J.; Jee, J.G.; Sung, S.H.; Kim, H.P. Bisdemethoxycurcumin Induces Apoptosis in activated hepatic stellate cells via cannabinoid receptor 2. Molecules, 2015, 20(1), 1277-1292.
-
(2015)
Molecules
, vol.20
, Issue.1
, pp. 1277-1292
-
-
Lee, P.J.1
Woo, S.J.2
Jee, J.G.3
Sung, S.H.4
Kim, H.P.5
-
158
-
-
0018963804
-
Plasma delta-?9-?tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking
-
Ohlsson, A.; Lindgren, J.E.; Wahlen, A.; Agurell, S.; Hollister, L.; Gillespie, H. Plasma delta-?9-?tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin. Pharmacol. Ther., 1980, 28(3), 409-416.
-
(1980)
Clin. Pharmacol. Ther
, vol.28
, Issue.3
, pp. 409-416
-
-
Ohlsson, A.1
Lindgren, J.E.2
Wahlen, A.3
Agurell, S.4
Hollister, L.5
Gillespie, H.6
-
159
-
-
0037255987
-
Pharmacokinetics and pharmacodynamics of cannabinoids
-
Grotenhermen, F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin. Pharmacokinetics, 2003, 42(4), 327-360.
-
(2003)
Clin. Pharmacokinetics
, vol.42
, Issue.4
, pp. 327-360
-
-
Grotenhermen, F.1
-
160
-
-
84888641390
-
Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: An ex vivo study
-
Feinshtein, V.; Erez, O.; Ben-Zvi, Z.; Eshkoli, T.; Sheizaf, B.; Sheiner, E.; Holcberg, G. Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: an ex vivo study. Am. J. Obstet. Gynecol., 2013, 209(6), 573. e571-573. e515.
-
(2013)
Am. J. Obstet. Gynecol
, vol.209
, Issue.6
, pp. 573e571-573e515
-
-
Feinshtein, V.1
Erez, O.2
Ben-Zvi, Z.3
Eshkoli, T.4
Sheizaf, B.5
Sheiner, E.6
Holcberg, G.7
-
161
-
-
0019523565
-
Toxicity of short-term administration of cannabinoids to rhesus monkeys
-
Rosenkrantz, H.; Fleischman, R.W.; Grant, R.J. Toxicity of short-term administration of cannabinoids to rhesus monkeys. YTAAP, 1981, 58(1), 118-131.
-
(1981)
YTAAP
, vol.58
, Issue.1
, pp. 118-131
-
-
Rosenkrantz, H.1
Fleischman, R.W.2
Grant, R.J.3
-
162
-
-
83455262550
-
Safety and side effects of cannabidiol a cannabis sativa constituent
-
Machado Bergamaschi, M.; Helena Costa Queiroz, R.; Waldo Zuardi, A.; Crippa, A.S. Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr. Drug Saf., 2011, 6(4), 237-249.
-
(2011)
Curr. Drug Saf
, vol.6
, Issue.4
, pp. 237-249
-
-
Machado Bergamaschi, M.1
Helena Costa Queiroz, R.2
Waldo Zuardi, A.3
Crippa, A.S.4
-
163
-
-
33745929641
-
A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
-
Guzman, M.; Duarte, M.; Blazquez, C.; Ravina, J.; Rosa, M.; Galve-Roperh, I.; Sanchez, C.; Velasco, G.; Gonzalez-Feria, L. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br. J. Cancer, 2006, 95(2), 197-203.
-
(2006)
Br. J. Cancer
, vol.95
, Issue.2
, pp. 197-203
-
-
Guzman, M.1
Duarte, M.2
Blazquez, C.3
Ravina, J.4
Rosa, M.5
Galve-Roperh, I.6
Sanchez, C.7
Velasco, G.8
Gonzalez-Feria, L.9
-
164
-
-
84931840300
-
The antitumor action of cannabinoids on glioma tumorigenesis
-
Zogopoulos, P.; Korkolopoulou, P.; Patsouris, E.; Theocharis, S. The antitumor action of cannabinoids on glioma tumorigenesis. Histol. Histopathol., 2014, 30(6), 629-45.
-
(2014)
Histol. Histopathol
, vol.30
, Issue.6
, pp. 629-645
-
-
Zogopoulos, P.1
Korkolopoulou, P.2
Patsouris, E.3
Theocharis, S.4
-
165
-
-
0016425051
-
Analgesic effect of delta-?9-?tetrahydrocannabinol
-
Noyes, R.; Brunk, S.; Baram, D.A.; Canter, A. Analgesic Effect of delta-?9-?Tetrahydrocannabinol. J. Clin. Pharmacol., 1975, 15(2-?3), 139-143.
-
(1975)
J. Clin. Pharmacol
, vol.15
, Issue.2-3
, pp. 139-143
-
-
Noyes, R.1
Brunk, S.2
Baram, D.A.3
Canter, A.4
-
166
-
-
0018090510
-
Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain
-
Staquet, M.; Gantt, C.; Machin, D. Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain. Clin. Pharmacol. Ther., 1978, 23(4), 397-401.
-
(1978)
Clin. Pharmacol. Ther
, vol.23
, Issue.4
, pp. 397-401
-
-
Staquet, M.1
Gantt, C.2
Machin, D.3
-
167
-
-
0018145394
-
Effect of benzopyranoperidine, a delta-9-thc congener, on pain
-
Jochimsen, P.; Lawton, R.; VerSteeg, K.; Noyes Jr., R. Effect of benzopyranoperidine, a delta-9-THC congener, on pain. Clin. Pharmacol. Ther., 1978, 24(2), 223-227.
-
(1978)
Clin. Pharmacol. Ther
, vol.24
, Issue.2
, pp. 223-227
-
-
Jochimsen, P.1
Lawton, R.2
VerSteeg, K.3
Noyes, R.4
-
168
-
-
75949093107
-
Multicenter doubleblind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of thc: Cbd extract and thc extract in patients with intractable cancer-related pain
-
Johnson, J.R.; Burnell-Nugent, M.; Lossignol, D.; Ganae-Motan, E.D.; Potts, R.; Fallon, M.T. Multicenter, doubleblind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC: CBD extract and THC extract in patients with intractable cancer-related pain. J. Pain Symptom Manage., 2010, 39(2), 167-179.
-
(2010)
J. Pain Symptom Manage
, vol.39
, Issue.2
, pp. 167-179
-
-
Johnson, J.R.1
Burnell-Nugent, M.2
Lossignol, D.3
Ganae-Motan, E.D.4
Potts, R.5
Fallon, M.T.6
-
169
-
-
0004222283
-
On the preparations of the indian hemp or gunjah: Cannabis indica their effects on the animal system in health, and their utility in the treatment of tetanus and other convulsive diseases. Provincial rov med
-
O'Shaughnessy, W.B. On the preparations of the indian hemp, or gunjah: cannabis indica their effects on the animal system in health, and their utility in the treatment of tetanus and other convulsive diseases. Provincial rov Med. J. Retrosp. Med. Sci., 1843, 5(123), 363.
-
(1843)
J. Retrosp. Med. Sci
, vol.5
, Issue.123
, pp. 363
-
-
O'Shaughnessy, W.B.1
-
170
-
-
0006829117
-
Xl charas. The resin of indian hemp
-
BarlowáWood, T.; NewtonáSpivey, W.; HilláEasterfield, T. XL.-Charas. The resin of Indian hemp. J. Chem. Soc., Trans., 1896, 69, 539-546.
-
(1896)
J. Chem. Soc Trans
, vol.69
, pp. 539-546
-
-
BarlowáWood, T.1
Newtonáspivey, W.2
Hilláeasterfield, T.3
-
171
-
-
0035138027
-
Pharmacology and effects of cannabis: A brief review
-
Ashton, C.H. Pharmacology and effects of cannabis: a brief review. Br. J. Psychiatry, 2001, 178(2), 101-106.
-
(2001)
Br. J. Psychiatry
, vol.178
, Issue.2
, pp. 101-106
-
-
Ashton, C.H.1
-
172
-
-
0034883101
-
Medicinal use of cannabis: History and current status
-
Kalant, H. Medicinal use of cannabis: history and current status. Pain Res. Manag., 2001, 6(2), 80-94.
-
(2001)
Pain Res. Manag
, vol.6
, Issue.2
, pp. 80-94
-
-
Kalant, H.1
-
173
-
-
0035135376
-
Therapeutic aspects of cannabis and cannabinoids
-
Robson, P. Therapeutic aspects of cannabis and cannabinoids. Br. J. Psychiatry, 2001, 178(2), 107-115.
-
(2001)
Br. J. Psychiatry
, vol.178
, Issue.2
, pp. 107-115
-
-
Robson, P.1
-
174
-
-
0002454039
-
Structure of cannabidiol, a product isolated from the marihuana extract of Minnesota wild hemp. i
-
Adams, R.; Hunt, M.; Clark, J. Structure of cannabidiol, a product isolated from the marihuana extract of Minnesota wild hemp. I. J. Am. Chem. Soc., 1940, 62(1), 196-200.
-
(1940)
J. Am. Chem. Soc
, vol.62
, Issue.1
, pp. 196-200
-
-
Adams, R.1
Hunt, M.2
Clark, J.3
-
175
-
-
9444259343
-
Isolation of a physiologically active tetrahydrocannabinol from cannabis sativa resin
-
Wollner, H.; Matchett, J.R.; Levine, J.; Loewe, S. Isolation of a physiologically active tetrahydrocannabinol from Cannabis sativa resin. J. Am. Chem. Soc. 1942, 64(1), 26-29.
-
(1942)
J. Am. Chem. Soc
, vol.64
, Issue.1
, pp. 26-29
-
-
Wollner, H.1
Matchett, J.R.2
Levine, J.3
Loewe, S.4
-
176
-
-
0016677441
-
Isolation of two new cannabinoid acids from cannabis sativa l. of czechoslovak origin
-
Hanus, L.; Krejci, Z. Isolation of two new cannabinoid acids from Cannabis sativa L. of Czechoslovak origin. Acta Univ. Palackianae Olomucensis Facult. Med., 1975, 74, 161-166.
-
(1975)
Acta Univ Palackianae Olomucensis Facult. Med
, vol.74
, pp. 161-166
-
-
Hanus, L.1
Krejci, Z.2
-
177
-
-
0033660254
-
A historical overview of chemical research on cannabinoids
-
Mechoulam, R.; Hanus, L.r. A historical overview of chemical research on cannabinoids. Chem. Phys. Lipids, 2000, 108(1), 1-13.
-
(2000)
Chem. Phys. Lipids
, vol.108
, Issue.1
, pp. 1-13
-
-
Mechoulam, R.1
Hanus, L.R.2
-
178
-
-
27444431791
-
Structure+ synthesis of cannabigerol new hashish constituent
-
Gaoni, Y.; Mechoulam, R. Structure+ synthesis of cannabigerol new hashish constituent. Proc. Chem. Soc. Lond., 1964, 82.
-
(1964)
Proc. Chem. Soc. Lond
, vol.82
-
-
Gaoni, Y.1
Mechoulam, R.2
-
179
-
-
33947489961
-
Isolation structure, and partial synthesis of an active constituent of hashish
-
Gaoni, Y.; Mechoulam, R. Isolation, structure, and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc., 1964, 86(8), 1646-1647.
-
(1964)
J. Am. Chem. Soc
, vol.86
, Issue.8
, pp. 1646-1647
-
-
Gaoni, Y.1
Mechoulam, R.2
-
180
-
-
0013220058
-
Cannabichromene a new active principle in hashish
-
Gaoni, Y.; Mechoulam, R. Cannabichromene, a new active principle in hashish. Chem. Commun. (London), 1966(1), 20-21.
-
(1966)
Chem. Commun. (London
, vol.1
, pp. 20-21
-
-
Gaoni, Y.1
Mechoulam, R.2
-
181
-
-
0008193523
-
Chemical classification of plants. Xxxi. Hashish. 10. Cannabichromene, a new hashish component
-
Claussen, U.; Von Spulak, F.; Korte, F. Chemical classification of plants. XXXI. Hashish. 10. Cannabichromene, a new hashish component. Tetrahedron, 1966, 22(4), 1477-1479.
-
(1966)
Tetrahedron
, vol.22
, Issue.4
, pp. 1477-1479
-
-
Claussen, U.1
Von Spulak, F.2
Korte, F.3
-
182
-
-
0014442806
-
Cannabidivarin a new hashish constituent
-
Vollner, L.; Bieniek, D.; Korte, F. Hashish. XX. Cannabidivarin, a new hashish constituent. Tetrahedron Lett., 1969, (3), 145.
-
(1969)
Tetrahedron Lett
, vol.3
, pp. 145
-
-
Vollner, L.1
Bieniek, D.2
Korte, F.3
Hashish, X.X.4
-
183
-
-
0014525511
-
A new tetrahydrocannabinolic acid
-
Mechoulam, R.; Ben-Zvi, Z.; Yagnitinsky, B.; Shani, A. A new tetrahydrocannabinolic acid. Tetrahedron Lett., 1969, 10(28), 2339-2341.
-
(1969)
Tetrahedron Lett
, vol.10
, Issue.28
, pp. 2339-2341
-
-
Mechoulam, R.1
Ben-Zvi, Z.2
Yagnitinsky, B.3
Shani, A.4
-
184
-
-
0015221354
-
Isolation and structure of. Delta.+-tetrahydrocannabinol and other neutral cannabinoids from hashish
-
Gaoni, Y.; Mechoulam, R. Isolation and structure of. delta.+-tetrahydrocannabinol and other neutral cannabinoids from hashish. J. Am. Chem. Soc., 1971, 93(1), 217-224.
-
(1971)
J. Am. Chem. Soc
, vol.93
, Issue.1
, pp. 217-224
-
-
Gaoni, Y.1
Mechoulam, R.2
-
185
-
-
69149097969
-
Cannabinoid receptor ligands as potential anticancer agents-high hopes for new therapies?
-
Oesch, S.; Gertsch, J. Cannabinoid receptor ligands as potential anticancer agents-high hopes for new therapies? J. Pharm. Pharmacol., 2009, 61(7), 839-853.
-
(2009)
J. Pharm. Pharmacol
, vol.61
, Issue.7
, pp. 839-853
-
-
Oesch, S.1
Gertsch, J.2
-
186
-
-
0016804266
-
Antineoplastic activity of cannabinoids
-
Munson, A.; Harris, L.; Friedman, M.; Dewey, W.; Carchman, R. Antineoplastic activity of cannabinoids. J. Natl. Cancer Inst., 1975, 55(3), 597-602.
-
(1975)
J. Natl. Cancer Inst
, vol.55
, Issue.3
, pp. 597-602
-
-
Munson, A.1
Harris, L.2
Friedman, M.3
Dewey, W.4
Carchman, R.5
-
187
-
-
0003186089
-
Biosynthesis of cannabinoid acids
-
Shoyama, Y.; Yagi, M.; Nishioka, I.; Yamauchi, T. Biosynthesis of cannabinoid acids. Phytochemistry, 1975, 14(10), 2189-2192.
-
(1975)
Phytochemistry
, vol.14
, Issue.10
, pp. 2189-2192
-
-
Shoyama, Y.1
Yagi, M.2
Nishioka, I.3
Yamauchi, T.4
-
188
-
-
0029031421
-
Anandamide, an endogenous cannabinomimetic eicosanoid 'killing two birds with one stone' prostaglandins, leukot
-
Di Marzo, V.; Fontana, A. Anandamide, an endogenous cannabinomimetic eicosanoid:'killing two birds with one stone'. Prostaglandins, Leukot. Essent. Fatty Acids, 1995, 53(1), 1-11.
-
(1995)
Essent. Fatty Acids
, vol.53
, Issue.1
, pp. 1-11
-
-
Di Marzo, V.1
Fontana, A.2
-
190
-
-
32944469658
-
Sativex for the management of multiple sclerosis symptoms
-
Perras, C. Sativex for the management of multiple sclerosis symptoms. Issues Emerg Health Technol., 2005, (72), 1-4.
-
(2005)
Issues Emerg Health Technol
, vol.72
, pp. 1-4
-
-
Perras, C.1
-
191
-
-
33645816506
-
Sativex® clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain
-
Barnes, M.P. Sativex®: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain. Expert Opin. Pharmacother., 2006, 37(5), 607-15.
-
(2006)
Expert Opin. Pharmacother
, vol.37
, Issue.5
, pp. 607-615
-
-
Barnes, M.P.1
-
192
-
-
70949091684
-
Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer
-
Qamri, Z.; Preet, A.; Nasser, M.W.; Bass, C.E.; Leone, G.; Barsky, S.H.; Ganju, R.K. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer. Mol. Cancer Ther., 2009, 8(11), 3117-3129.
-
(2009)
Mol. Cancer Ther
, vol.8
, Issue.11
, pp. 3117-3129
-
-
Qamri, Z.1
Preet, A.2
Nasser, M.W.3
Bass, C.E.4
Leone, G.5
Barsky, S.H.6
Ganju, R.K.7
-
193
-
-
27744562012
-
Plasma membrane and lysosomal localization of cb1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells
-
Sarnataro, D.; Grimaldi, C.; Pisanti, S.; Gazzerro, P.; Laezza, C.; Zurzolo, C.; Bifulco, M. Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. FEBS Lett., 2005, 579(28), 6343-6349.
-
(2005)
FEBS Lett
, vol.579
, Issue.28
, pp. 6343-6349
-
-
Sarnataro, D.1
Grimaldi, C.2
Pisanti, S.3
Gazzerro, P.4
Laezza, C.5
Zurzolo, C.6
Bifulco, M.7
-
194
-
-
29144447456
-
Anandamide inhibits adhesion and migration of breast cancer cells
-
Grimaldi, C.; Pisanti, S.; Laezza, C.; Malfitano, A.M.; Santoro, A.; Vitale, M.; Caruso, M.G.; Notarnicola, M.; Iacuzzo, I.; Portella, G. Anandamide inhibits adhesion and migration of breast cancer cells. Exp. Cell Res., 2006, 312(4), 363-373.
-
(2006)
Exp. Cell Res
, vol.312
, Issue.4
, pp. 363-373
-
-
Grimaldi, C.1
Pisanti, S.2
Laezza, C.3
Malfitano, A.M.4
Santoro, A.5
Vitale, M.6
Caruso, M.G.7
Notarnicola, M.8
Iacuzzo, I.9
Portella, G.10
-
195
-
-
77952627758
-
A role for l-?lysophosphatidylinositol and gpr55 in the modulation of migration, orientation and polarization of human breast cancer cells
-
Ford, L.A.; Roelofs, A.J.; Anavi-?Goffer, S.; Mowat, L.; Simpson, D.G.; Irving, A.J.; Rogers, M.J.; Rajnicek, A.M.; Ross, R.A. A role for L-?lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells. Br. J. Pharmacol., 2010, 160(3), 762-771.s
-
(2010)
Br. J. Pharmacol
, vol.160
, Issue.3
, pp. 762-771s
-
-
Ford, L.A.1
Roelofs, A.J.2
Anavi-Goffer, S.3
Mowat, L.4
Simpson, D.G.5
Irving, A.J.6
Rogers, M.J.7
Rajnicek, A.M.8
Ross, R.A.9
-
196
-
-
57649242673
-
A high cannabinoid cb 1 receptor immunoreactivity is associated with disease severity and outcome in prostate cancer
-
Chung, S.C.; Hammarsten, P.; Josefsson, A.; Stattin, P.; Granfors, T.; Egevad, L.; Mancini, G.; Lutz, B.; Bergh, A.; Fowler, C.J. A high cannabinoid CB 1 receptor immunoreactivity is associated with disease severity and outcome in prostate cancer. Eur. J. Cancer, 2009, 45(1), 174-182.
-
(2009)
Eur. J. Cancer
, vol.45
, Issue.1
, pp. 174-182
-
-
Chung, S.C.1
Hammarsten, P.2
Josefsson, A.3
Stattin, P.4
Granfors, T.5
Egevad, L.6
Mancini, G.7
Lutz, B.8
Bergh, A.9
Fowler, C.J.10
-
197
-
-
61449211120
-
Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in human prostate carcinoma
-
Czifra, G.; Varga, A.; Nyeste, K.; Marincsák, R.; Tóth, B.I.; Kovács, I.; Kovács, L.; Bíró, T. Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in human prostate carcinoma. J. Cancer Res. Clin. Oncol., 2009, 135(4), 507-514.
-
(2009)
J. Cancer Res. Clin. Oncol
, vol.135
, Issue.4
, pp. 507-514
-
-
Czifra, G.1
Varga, A.2
Nyeste, K.3
Marincsák, R.4
Tóth, B.I.5
Kovács, I.6
Kovács, L.7
Bíró, T.8
-
198
-
-
77956278506
-
Cannabinoid receptor-dependent and-independent anti-proliferative effects of omega-3 ethanolamides in androgen receptorpositive and-negative prostate cancer cell lines
-
Brown, I.; Cascio, M.G.; Wahle, K.W.; Smoum, R.; Mechoulam, R.; Ross, R.A.; Pertwee, R.G.; Heys, S.D. Cannabinoid receptor-dependent and-independent anti-proliferative effects of omega-3 ethanolamides in androgen receptorpositive and-negative prostate cancer cell lines. Carcinogenesis, 2010, 31(9), 1584-1591.
-
(2010)
Carcinogenesis
, vol.31
, Issue.9
, pp. 1584-1591
-
-
Brown, I.1
Cascio, M.G.2
Wahle, K.W.3
Smoum, R.4
Mechoulam, R.5
Ross, R.A.6
Pertwee, R.G.7
Heys, S.D.8
-
199
-
-
78651383853
-
The putative cannabinoid receptor gpr55 defines a novel autocrine loop in cancer cell proliferation
-
Pineiro, R.; Maffucci, T.; Falasca, M. The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation. Oncogene, 2011, 30(2), 142-152.
-
(2011)
Oncogene
, vol.30
, Issue.2
, pp. 142-152
-
-
Pineiro, R.1
Maffucci, T.2
Falasca, M.3
-
200
-
-
78650808693
-
Cannabinoid receptors, cb1 and cb2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis
-
Preet, A.; Qamri, Z.; Nasser, M.W.; Prasad, A.; Shilo, K.; Zou, X.; Groopman, J.E.; Ganju, R.K. Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis. Cancer Prev. Res., 2011, 4(1), 65-75.
-
(2011)
Cancer Prev. Res
, vol.4
, Issue.1
, pp. 65-75
-
-
Preet, A.1
Qamri, Z.2
Nasser, M.W.3
Prasad, A.4
Shilo, K.5
Zou, X.6
Groopman, J.E.7
Ganju, R.K.8
-
201
-
-
84947648665
-
Cannabinoid receptor cb2 is involved in tetrahydrocannabinolinduced anti-inflammation against lipopolysaccharide in mg-63 cells
-
Yang, L.; Li, F.-F.; Han, Y.-C.; Jia, B.; Ding, Y. Cannabinoid receptor CB2 Is involved in tetrahydrocannabinolinduced anti-inflammation against lipopolysaccharide in MG-63 cells. Mediators Inflamm., 2015, 2015. 362126.
-
(2015)
Mediators Inflamm
, vol.2015
, pp. 362126
-
-
Yang, L.1
Li, F.-F.2
Han, Y.-C.3
Jia, B.4
Ding, Y.5
-
202
-
-
84875529266
-
Cannabinoid receptor 2 is upregulated in melanoma
-
Zhao, Z.; Yang, J.; Zhao, H.; Fang, X.; Li, H. Cannabinoid receptor 2 is upregulated in melanoma. J. Cancer Res. Ther., 2012, 8(4), 549.
-
(2012)
J. Cancer Res. Ther
, vol.8
, Issue.4
, pp. 549
-
-
Zhao, Z.1
Yang, J.2
Zhao, H.3
Fang, X.4
Li, H.5
-
203
-
-
0031062297
-
Cannabinoid receptors cb1 and cb2: A characterization of expression and adenylate cyclase modulation within the immune system
-
Schatz, A.R.; Lee, M.; Condie, R.B.; Pulaski, J.T.; Kaminski, N.E. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. YTAAP, 1997, 142(2), 278-287.
-
(1997)
YTAAP
, vol.142
, Issue.2
, pp. 278-287
-
-
Schatz, A.R.1
Lee, M.2
Condie, R.B.3
Pulaski, J.T.4
Kaminski, N.E.5
-
204
-
-
0032566430
-
Delta-9-tetrahydrocannabinol induces apoptosis in c6 glioma cells
-
Sánchez, C.; Galve-Roperh, I.; Canova, C.; Brachet, P.; Guzmán, M. Delta-9-Tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett., 1998, 436(1), 6-10.
-
(1998)
FEBS Lett
, vol.436
, Issue.1
, pp. 6-10
-
-
Sánchez, C.1
Galve-Roperh, I.2
Canova, C.3
Brachet, P.4
Guzmán, M.5
-
205
-
-
17344380844
-
Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
-
Galve-Roperh, I.; Sánchez, C.; Cortés, M.L.; del Pulgar, T.G.; Izquierdo, M.; Guzmán, M. Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat. Med., 2000, 6(3), 313-319.
-
(2000)
Nat. Med
, vol.6
, Issue.3
, pp. 313-319
-
-
Galve-Roperh, I.1
Sánchez, C.2
Cortés, M.L.3
Del Pulgar, T.G.4
Izquierdo, M.5
Guzmán, M.6
-
206
-
-
33744948790
-
Effects of peripheral cannabinoid receptor ligands on motility and polarization in neutrophil-like hl60 cells and human neutrophils
-
Kurihara, R.; Tohyama, Y.; Matsusaka, S.; Naruse, H.; Kinoshita, E.; Tsujioka, T.; Katsumata, Y.; Yamamura, H. Effects of peripheral cannabinoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils. J. Biochem., 2006, 281(18), 12908-12918.
-
(2006)
J. Biochem
, vol.281
, Issue.18
, pp. 12908-12918
-
-
Kurihara, R.1
Tohyama, Y.2
Matsusaka, S.3
Naruse, H.4
Kinoshita, E.5
Tsujioka, T.6
Katsumata, Y.7
Yamamura, H.8
-
207
-
-
0029012765
-
Stimulation of cannabinoid receptor cb1 induces krox-24 expression in human astrocytoma cells
-
Bouaboula, M.; Bourrié, B.; Rinaldi-Carmona, M.; Shire, D.; Le Fur, G.; Casellas, P. Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells. J. Biochem., 1995, 270(23), 13973-13980.
-
(1995)
J. Biochem
, vol.270
, Issue.23
, pp. 13973-13980
-
-
Bouaboula, M.1
Bourrié, B.2
Rinaldi-Carmona, M.3
Shire, D.4
Le Fur, G.5
Casellas, P.6
-
208
-
-
79955865808
-
Stimulation of the midkine/alk axis renders glioma cells resistant to cannabinoid antitumoral action
-
Lorente, M.; Torres, S.; Salazar, M.; Carracedo, A.; Hernández-Tiedra, S.; Rodríguez-Fornés, F.; García-Taboada, E.; Meléndez, B.; Mollejo, M.; Campos-Martín, Y. Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action. Cell Death Differ., 2011, 18(6), 959-973.
-
(2011)
Cell Death Differ
, vol.18
, Issue.6
, pp. 959-973
-
-
Lorente, M.1
Torres, S.2
Salazar, M.3
Carracedo, A.4
Hernández-Tiedra, S.5
Rodríguez-Fornés, F.6
García-Taboada, E.7
Meléndez, B.8
Mollejo, M.9
Campos-Martín, Y.10
-
209
-
-
33750298256
-
Overexpression of cannabinoid receptors cb1 and cb2 correlates with improved prognosis of patients with hepatocellular carcinoma
-
Xu, X.; Liu, Y.; Huang, S.; Liu, G.; Xie, C.; Zhou, J.; Fan, W.; Li, Q.; Wang, Q.; Zhong, D. Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma. Cancer Gene Cytogenet., 2006, 171(1), 31-38.
-
(2006)
Cancer Gene Cytogenet
, vol.171
, Issue.1
, pp. 31-38
-
-
Xu, X.1
Liu, Y.2
Huang, S.3
Liu, G.4
Xie, C.5
Zhou, J.6
Fan, W.7
Li, Q.8
Wang, Q.9
Zhong, D.10
-
210
-
-
34548599988
-
Physiological doses of cannabinoids do not adversely affect mcl viability
-
Richardson, S.J.; Widmer, M.; Zajicek, J.; Rule, S.A. Physiological doses of cannabinoids do not adversely affect MCL viability. Leuk. Lymphoma, 2007, 48(9), 1855-1857.
-
(2007)
Leuk. Lymphoma
, vol.48
, Issue.9
, pp. 1855-1857
-
-
Richardson, S.J.1
Widmer, M.2
Zajicek, J.3
Rule, S.A.4
-
211
-
-
78651236037
-
Role for cannabinoid receptors in human proximal tubular hypertrophy
-
Jenkin, K.A.; McAinch, A.J.; Grinfeld, E.; Hryciw, D.H. Role for cannabinoid receptors in human proximal tubular hypertrophy. Cell. Physiol. Biochem., 2010, 26(6), 879.
-
(2010)
Cell. Physiol. Biochem
, vol.26
, Issue.6
, pp. 879
-
-
Jenkin, K.A.1
McAinch, A.J.2
Grinfeld, E.3
Hryciw, D.H.4
-
212
-
-
0018198253
-
Influence of delta-9-tetrahydrocannabinol on cell proliferation and macromolecular biosynthesis in human cells
-
Mon, M.J.; Jansing, R.L.; Doggett, S.; Stein, J.L.; Stein, G.S. Influence of delta-9-tetrahydrocannabinol on cell proliferation and macromolecular biosynthesis in human cells. Biochem. Pharmacol., 1978, 27(13), 1759-1765.
-
(1978)
Biochem. Pharmacol
, vol.27
, Issue.13
, pp. 1759-1765
-
-
Mon, M.J.1
Jansing, R.L.2
Doggett, S.3
Stein, J.L.4
Stein, G.S.5
-
213
-
-
77950557553
-
The dual effects of delta-9-tetrahydrocannabinol on cholangiocarcinoma cells: Anti-invasion activity at low concentration and apoptosis induction at high concentration
-
Leelawat, S.; Leelawat, K.; Narong, S.; Matangkasombut, O. The dual effects of delta-9-tetrahydrocannabinol on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration. Cancer Invest., 2010, 28(4), 357-363.
-
(2010)
Cancer Invest
, vol.28
, Issue.4
, pp. 357-363
-
-
Leelawat, S.1
Leelawat, K.2
Narong, S.3
Matangkasombut, O.4
-
214
-
-
0031060674
-
Failure of cannabinoid compounds to stimulate estrogen receptors
-
Ruh, M.F.; Taylor, J.A.; Howlett, A.C.; Welshons, W.V. Failure of cannabinoid compounds to stimulate estrogen receptors. Biochem. Pharmacol., 1997, 53(1), 35-41.
-
(1997)
Biochem. Pharmacol
, vol.53
, Issue.1
, pp. 35-41
-
-
Ruh, M.F.1
Taylor, J.A.2
Howlett, A.C.3
Welshons, W.V.4
-
215
-
-
84891802683
-
Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (vdac1) by cannabidiol: A novel mechanism for cannabinoid-induced cell death
-
Rimmerman, N.; Ben-Hail, D.; Porat, Z.; Juknat, A.; Kozela, E.; Daniels, M.; Connelly, P.; Leishman, E.; Bradshaw, H.; Shoshan-Barmatz, V. Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death. Cell Death Dis. 2013, 4(12), e949.
-
(2013)
Cell Death Dis
, vol.4
, Issue.12
, pp. e949
-
-
Rimmerman, N.1
Ben-Hail, D.2
Porat, Z.3
Juknat, A.4
Kozela, E.5
Daniels, M.6
Connelly, P.7
Leishman, E.8
Bradshaw, H.9
Shoshan-Barmatz, V.10
-
216
-
-
0017253510
-
The inhibition of DNA synthesis by cannabinoids
-
Carchman, R.; Harris, L.; Munson, A. The inhibition of DNA synthesis by cannabinoids. Cancer Res., 1976, 36(1), 95-100.
-
(1976)
Cancer Res
, vol.36
, Issue.1
, pp. 95-100
-
-
Carchman, R.1
Harris, L.2
Munson, A.3
|